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GENERAL INTRODUCTION
Neoplastic lesions, or tumours, consist of many 
cells whose multiplication is no longer subject to 
normal homeostatic control, and which may vary both 
morphologically and biochemically from the cells of 
the tissue of origin. The biological characteristics 
of the cancer cell would seem to indicate that it is 
a cell which has specialised to growth (Busch, 1954), 
and to survival under adverse conditions. Eor example, 
cells of the brain or heart die within minutes when 
exposed to an environment lacking in oxygen or containing 
cyanide. On the other hand, tumour cells have remained 
viable for as long as three days in an environment 
containing cyanide, and totally lacking in oxygen 
(Warburg, 1926), Another important property of cancer 
cells appears to be a loss of mutual adhesiveness 
(Mercer and Easty, 1961), which allows them to become 
detached from the tumour mass. The tumour cells may 
then spread through the bloodstream or lymph vessels 
and grow as secondary tumours (métastasés) at sites 
distal to the original cancer.
The genesis of such a malignant growth has been 
attributed to many agents, but whatever the oncogenic 
agent, the pathogenicity of the growth is extreme, 
although the nature of the changes leading to the death
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of the host is not clear. Some tumours will kill 
because of the anatomical site of their growth; as Mider 
(1955) put it: **unrelieved obstruction of the ureters, 
the aqueduct of Sylvius or the gastrointestinal tract is 
incompatible with life". Invasion of vital organs, either 
by primary tumour growth, or by métastasés, again provides 
a readily understandable cause of death. However, the 
death of the host can equally be caused by a more general 
effect of the tumour upon the metabolism, and it was with 
some of these systemic effects of the growth of the tumour 
that this work has been concerned*
Tumour growth and metabolism
(i) The nature of the cancer coll
Neoplastic growth can vary over a wide spectrum 
from benign tumours to malignant growths. A benign tumour 
is localised, slow-growing, well-differentiated and 
generally harmless throughout the life-span of the organism. 
Benign * cancer'' is essentially an exaggeration of the 
process of hyperplasia, whereby an organ grows by cell 
division (as opposed to hypertrophy, or cell enlargement), 
and which is of normal occurrence even in healthy animals 
(Reid, 1965). Malignant tumours, on the other hand, may 
obliterate the organ in which they arise, and give rise to
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métastasés in other tissues. Malignant tumours can arise 
from the cells of all tissues; carcinomas originate in 
epithelial tissue such as skin and breast, while sarcomas 
arise from non-haematopoietic mesenchymal tissues, such 
as connective, vascular or muscular tissues. Malignant 
growths vary in the extent to which they retain the 
structure and functional capacity of the tissue in which 
they originated, but frequently there is anaplasia, or 
loss of characteristic tissue structure,
(ii) Amino-acid and protein metabolism of tumours
An Important property reported as being characterist: 
of tumour cells is the capacity to take up amino-acids 
and concentrate them, Ehrlich carcinoma ascites cells 
show highly concentrative uptake of such amino-acids as 
glycine and alanine both iji vivo and in vitro 
(Ohristonsen q± al,, 1954; Christensen and Riggs, 1952; 
Christensen ei , 1948), The ratio of the intracellular 
concentration of amino-acids to the extracellular 
concentration of amino-acids in tumour cells found by 
these workers ranged from 1.3 to 20.6. Mider et (1948) 
suggested that tumours act as *nitrogen traps’ in that 
they appear to concentrate amino-acids, but not to contribute 
to the nitrogen exchange of the host. Wiseman and
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Ghadially (1958) advanced a hypothesis on this basis to 
explain the anorexia and cachexia of the host, stating 
that the tumour possesses enhanced power for the 
concentration of amino-acids, due to the maintenance of 
a low intracellular free amino-acid level by the rapid 
processes of protein synthesis in neoplastic cells. This 
view was consistent with the early work of LePage ^  ,
(1952), who injected radioactivoly-laboiled glycine into 
rats bearing transplanted tumours. The tumours were 
subsequently found to increase continuously in total 
weight and in total protein radioactivity, even under 
conditions of complete fast, while normal tissues lost 
radioactivity. Thus the proteins of the tumour were 
evidently not available to the host under conditions wheie 
normal tissues were grossly catabolised. El Mehairy (1950) 
reported an increase of alpha-amino-nitrogen in the blood 
of tumour-bearing mice. Wu and Bauer (i960) found 
reductions in the levels of some free amino-acids in muscle 
of rats bearing a Walker 256 carcinoma, and increases in 
the levels of most of those amino-acids in the plasma of 
the tumour-bearing animal. These results they took to be 
consistent with the liberation of amino-acids from muscle 
into plasma, followed by translocation to the tumour.
It should be noted, however, that their method for the
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estimation of amino-acids depended upon paper chromatography, 
so that the data obtained should be treated with some 
caution. In fact, their values for the amino-acid levels 
in normal rat muscle and plasma do not agree closely with 
more recent data obtained by column chromatographic analysis 
(Scharff and Wool, 1964; Schimassek and Gerok, 1965; 
Christophe ^  al., 1971), Auerbach and Weisnan (1958) 
found an increased concentration of plasma aromatic amino- 
acids in cancerous animals, and higher levels of serum 
tryptophan have been reported by Brackenridge (i960).
On the other hand, although Christensen ^  al,,
(1948, 1954) found that ascites cells could concentrate 
amino-acids in vivo and in vitro, the in vivo experiments 
indicated that the concentrative capacity of the tumour 
cells was not equal to that of liver, although uptake into 
the tumour cells exceeded that into kidney and skeletal 
muscle. Christensen and Stretcher (1948) have shown that 
concentration of amino-acids by tumour cells is a property 
shared by foetal tissue, and Riggs and Walker (1958) have 
demonstrated the same propensity in the tissues of young, 
growing rats. More recent studies have indeed indicated that 
most amino-acids enter cells by an active transport process 
(Christensen and Clifford, 1963; Johnstone and Scholefield, 
1965; Pardee, 196?).
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Greenloos and LePage (1955) found that labelled 
ascites cells transferred to unlabelled hosts lost 99^  of 
their radioactivity per day. Forssberg and Rovesz (1957) 
studied the loss of radioactivity of two Ehrlich ascites 
tumours labelled with ^^0-glycine and ^^8-methionine, and 
discovered that loss of radioactivity occurred when the 
tumour protein was labelled with glycine, but not when it 
was labelled with methionine. Finlayson ab a%.,(1959) used 
a number of Landschutz ascites cells labelled with several 
different radioactive amino-acids, and concurred with 
Forssberg and Revesz (1957), concluding that the loss of 
radioactivity observed was due entirely to intracellular 
turnover of the tumour protein, with consequent réutilisation 
of the labelled amino-acid * The work of Jordan e;t al. (1959) 
did not agree with this mechanism for the loss of radio­
activity from labelled tumour protein. Employing a tissue 
culture of Walker 256 carcinoma cells, the proteins of 
which were labelled with ^^0-lysine, they discovered thab 
transfer of labelled cells to unlabelled medium resulted 
in a not loss of 12.99^  of the radioactivity per day from 
the cellsc Fart of this loss appeared to be due to turnover 
of the tumour protein, while the remainder could be accounted 
for as net transfer of radioactivity to the medium, 
possibly in the form of intact protein.
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Transplanted tumours appear to vary considerably 
in their response to alterations in the protein content of 
the diet. Mice on a low-protein diet, and in negative 
nitrogen balance, exhibited tumour growth at 75^ of the 
rate in control mice on an adequate protein intake (White,
1945; White and Belkin, 1945)* This has been confirmed in 
hepatoma-bearing rats (Voegtlin and Thompson, 1949).
The latent period, but not the growth rate, of the Walker 
256 carcinoma is affected by nitrogen deprivation (Green 
et al.. 1950). The growth rate of Sarcoma R-1 and the 
Flexner-Jobling hepatoma were both reduced with the host 
on a protein-free diet (Babson, 1954), the growth of the 
hepatoma being more dependent upon dietary protein than the 
sarcoma. Supplementation of a 12^ casein diet with methionin 
increased the carcass weight and decreased the tumour 
weight of Sarcoma R-1 (Hilf, 1956). A negative nitrogen 
balance induced by cortisone administration decreases the 
rate of growth of the Walker tumour (Ingle al., 1950), 
indicating that a tumour can obtain nitrogen from a host 
that is in negative nitrogen balance, but not with the ease 
that pertains when the host is in positive nitrogen balance. 
Force-feeding rats bearing the Walker tumour delayed the 
loss of carcass weight, but only temporarily (Begg and 
Dickinson, 1951; Stewart and Begg, 1953a,b; Terepka and
Waterhouse, 1956).
It now seems clear that the tumour does 
participate in some degree of dynamic exchange with host 
tissue nitrogen. It would appear, furthermore, that 
tumours have an advantage, shared to some extent by normal 
growing cells, of the ability to concentrate and conserve 
amino-acids for protein synthesis. They are not ’nitrogen 
traps’ as Mider ^  al. (1948) visualized them, but they 
do seem to have a tendency to conserve their proteins 
and amino-acids to a greater extent than do most normal 
tissues.
(ill) Protein utilisation by the tumour
There is considerable evidence that plasma proteins 
may be taken up and utilised by cancer cells, without the 
initial step of extratûmoural hydrolysis. The possibility 
was first suggested by Babson and Winnick (1954), who 
injected a radioactive amino-acid into tumour-bearing 
animals. Upon subsequent flooding of the rat with the non­
radioactive isotope of the amino-acid, a dilution of 
protein radioactivity in normal and tumour tissues was 
noted. However, the injection of labelled plasma proteins 
followed by cold amino-acid did not produce a comparable 
dilution, and the uptake of label into the tumour cells was
10
very much greater than that into liver and kidney cells*
Busch and Greene (1955) and Busch ^  aJ* (1956) showed that 
the uptake of free ^^0-glycine by tumour protein was very 
much less than the uptake into several other normal tissue^ 
such as pancreas and intestine. At the same time, these 
workers confirmed that the uptake of labelled amino-acid 
from labelled plasma protein was very much higher in tumour 
protein than in proteins from any other tissue. Furthermore, 
albumin labelled with any one of several amino-acids led 
to the same specific activity in tumour protein upon injectior 
into a tumour-b earing animal. Injection of the separate 
amino-acids led to widely differing specific activities in 
the tumour protein (Busch ^  ad.., 1961). This finding 
appears to rule out the possibility that albumin ie hydrolyse< 
before entering the tumour cell.
Metabolism of the tumour-bearing host
(i) The tuiziour-host relationship
The study of the metabolism of the tumour—bearing 
animal is inseparable from the study of the systemic effects 
of the tumour, for there is scarcely a tissue or metabolic 
process in the host animal which is not affected either 
directly or indirectly by the growth of a tumour.
Begg (1955) has defined tumourvhost relationships as
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’those changes produced in the tissues of the host 
remote from the tumour, and in which no evidence of 
metastatic malignant cells is found’. It is true that 
many of the effects found in the cancerous animal, 
particularly cachexia, are also characteristic of 
haemorrhage, malnutrition and infection (Willis, 1948). 
However, it is equally true that the effects of a tumour 
may be noted when infection and haemorrhage are absent, 
invasion is minimal and nutrition adequate (Fenninger and 
Mider, 1954; Mider, 1955).
Clinically and experimentally, the most striking 
of the systemic effects of the tumour is the cachectic 
state of the cancerous patient or the tumour-bearing 
animal. Cachexia is characterised by weakness, anorexia, 
depletion of host components, electrolyte and water 
abnormalities, and a progressive fading of vital functions 
(Costa, 1963).
The effect of the tumour can be exerted long before 
the tumour has reached its greatest size or maximal growth 
rate. Thus, oedema in rats bearing the Walker 256 carcinome 
is greatest during the early stages of tumour growth 
(McBwan and Haven, 1941). The caloric balance of rats is 
less positive during the period of tumour induction than 
either before transplantation or after the tumour becomes
12
palpable (Pratt and Putney, 1958).
Study of the water content of tissues of the 
tumour-bearing rat has led to inconsistent results. Ràts 
bearing a PIexner-Jobling carcinoma, Jensen sarcoma 
(Schlotteman and Rubenov, 1932), hepatoma (Aoki, 1938) 
or Walker 256 carcinoma (McEwan, 1955) showed a slight 
increase in the water content of various organs such as 
liver, kidney and skeletal muscle. These increases were ii 
general less than 10^, and the calculations did not take 
into account differing tumour weight, or the loss of weight 
due to lipid loss (Haven et al., 1949).
More recently, studies by Toal ^  al. (1961), in 
which the carcass was analysed separately from the tumour, 
showed a slight but consistent decrease in carcass water 
concentration, 25 to 30 days after Walker 256 tumour 
transplantation.
(ii) Protein metaboli sm
A prominent tumour-host effect is the ability of 
the tumour to cause mobilisation of host protein for its 
own utilisation. Sherman ^  aJL. ,(1950) studied the nitrogen 
content of various tissues of rats bearing the Walker 256 
carcinoma, and found that skeletal muscle contributed most
nitrogen to the tumour, In cancerous patients too, there 
is evidence of a fall in certain muscle protein components. 
Ritter (1958) separated muscle protein into three fractions 
by electrophoresis, and found that cancerous patients had 
decreased amounts of two of these fractions. Sobel (1966) 
fractionated abdominal muiâcle from rats bearing a Walker 
256 carcinoma into 11 Wb-ffactions, and quantitatively 
compared the results with normal, Starved ahd cortidone 
treated rats. Although he found approximately equal losses 
of carcass protein in severely starved animals, in animals 
which responded most acutely to cortisone treatment, and 
in the animals bearing the largest tumours, the patterns of 
loss of individual protein fractions from abdominal muscle 
were distinctly different with each treatment. In the case 
of the tumour-b earing animals, the loss appeared to be 
principally from the contractile proteins of muscle.
Not all tissues of the tumour-b earing animal suffer 
a depletion of protein. Renal nitrogen did not alter during 
the growth of the Walker 256 carcinoma in rats (Sherman et 
al., 1850), while the spleen and liver have actually been 
shown to increase in nitrogen content in the presence of a 
growing tumour (Sherman ^  al*j 1950; Yeakel and Tobias, 
I95I; Clark and Goodlad, I960). The observation of
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Norberg and Greenberg (1951) that glycine was incorporated 
more readily into the plasma, liver and spleen of tumour- 
bearing mice than control mice, but less readily into 
muscle, is in keeping with the findings of Sherman et al. 
(1950). ^^0-labelled histidine behaved like glycine in 
respect to rate of incorporation into liver protein, and 
also exhibited increased incorporation into the nucleic acid 
of host liver (Reid et al#, 1956).
The ability to demand nitrogen for protein synthesis
is not confined to cancer. The pregnant rat maintained on 
a protein-free diet from the 11th day of gestation until 
parturition can produce viable, although small, young 
(Seegers, 1937). The growth of a tumour during pregnancy 
does not appear to materially affect the mean foetal weight 
(Paschkis al., 1956), Liver regeneration after partial 
. hePatectomy in mice bearing an ascites tumour produced 
limitation of tumour growth, and the rate of liver 
regeneration was less in the presence of the tumour (Straube 
and Hill, 1956-), suggesting competition for a common 
amino-acid supply. Once again the pattern emerges of a
rapidly growing normal tissue able to compete with a tumour
for protein precursors.
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( 1 ii) Liver catalase
Cancer interferes with the iron-containing enzyme 
catalase, and with the production of cytochrome c 
(Kampschmidt ^  a2., 1959).
The activity of liver catalase in the animal bearing 
a tumour has been studied more intensively than any other 
tissue enzyme in cancer. The depression of kidney catalase 
is much less than that of liver catalase, and the level of 
blood catalase in the tumour-bearing animal is normal 
(G-reenstein and Andervont, 1942b). The demonstration of 
different rates of synthesis of catalase in different tissues 
(Theorell et aJ., 1951) may explain the variation in tissue 
response, but nevertheless, the effect of the tumour appears 
to be selective. Hot all liver enzymes are depressed by 
the presence of a tumour, and not all tissues are affected 
to the same degree (Greenstein, 1954).
The catalase effect is not specific for the animal 
bearing a tumour# Depression of catalase has been observed 
after radiation (Deinstein et aJ.. ,1950), and during the 
growth of a chronic granuloma (Pounce and Shandwise, 1950). 
Nutrition (Rechcigl and Price, 1968) and hormonal status 
(Adams, 1952) both influence the level of catalase activity 
in the liver. Nevertheless, there is an effect on liver
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catalase directly related to the presence of a tumour.
The degree of depression of catalase activity bore a relation 
to the size of the tumour (Greenstein and Jenrette, 1941; 
Begg, 1951), and a malignant tumour produced a greater 
depression of catalase activity than a benign tuinour of 
similar size and growth rate (Begg et al., 1953b). Further, 
liver catalase activity has been shown to return to normal 
upon surgical removal of the tumour (Greenstein and Andervont 
1942a). Nor is the effect confined to mammals, for renal 
carcinoma in the frog (Lucke and Berwick, 1954) and tumour 
growth on the chorioallantoic membrane (Stavinski and Stein, 
1951) has been reported to produce a depression of liver 
catalase activity.
Rechcigl ^  al. (1962) and Rechcigl and Sidransky 
(196 )^ carried out studies on the synthesis of catafese in 
rat hepatomas possessing unusually high levels of catalase 
activity. Contrary to the situation in normal tissues, the 
catalase level of these hepatomas was neither affected by 
cachexia in the tumour-bearing host, nor altered under the 
stress of a protein-free diet. It was shown that in rats 
bearing the Morris 5123 hepatoma the rate of catalase 
synthesis was about four times greater in the liver than 
in the tumour, whilst the first order rate constant for 
catalase destruction was practically the same in both types
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of tissue. This may explain the lack of response of the 
5123 hepatoma catalase to factors which cause a marked 
reduction of the activity of the enzyme in the tissues of 
the host.
Mechanism of tumour action on host metabolism
(i) The *nitrogen trap* theory
It seems unlikely that any unitary hypothesis can 
be formulated to explain the systemic effects of tumour 
growth upon the metabolism of the host. Costa (1963) 
stated that ’’the devastations produced in the host by cancer 
are the compound result of a manifold impingement on 
organs and functions between destruction, attempted repair 
and homeostasis”.
Certainly, the nitrogen trap theory as proposed 
by Mider e;t a2, (1948), and expanded by Wiseman and Ghadially 
(1958), which depends upon the enhanced ability of the 
neoplastic cell to concentrate amino-acids to the eventual 
detriment of the'host, has been unable to explain many of 
the effects observed in the protein metabolism of the 
host and tumour discussed above. It now seems that the 
proven ability of the tumour to retain a large proportion 
of its nitrogen under conditions of general protein
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catabolism in the host (LePage et al., 1952; Greenlees and 
LePage, 1955), while contributing towards the ability of 
the tumour to grow under unfavourable conditions, cannot 
be directly responsible for tissue protein breakdown.
Because the depleting effect of the tumour on host 
tissues extends to many of the endocrine organs (Sherman 
et al., 1950; Kampschmidt et ad.,, 1959), the possibility 
exists that disruption of the normal system of hormonal 
balance may occur.
(ii) Hormones and the.tumour-host relationship
The study of the role of the tumour in alteration 
of the hormonal balance of the host is complicated by several 
observations that a reciprocal relationship can exist.
Quite apart from the involvement of hormones in tumourigenesi 
(Gardner, 1957), many tumours appear to be hormone dependent 
(Noble, 1957), Go ran son ejt aJ., (1955) found that the presence 
of alloxan diabetes in the host animal lowered the percentage 
of takes and reduced the size of intraperitoneally 
transplanted Novikoff hepatomas. In the animals in which 
the tumour did take, blood-sugar was lowered in the diabetic 
tumour-bearing animals as opposed to the tumour-bearing 
controls, and the diabetic animals lived longer. It may 
be that the Increased availability of glucose to the tumour
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due to the increased blood level in the diabetic animal, 
may well have delayed the cachectic effect of the tumour, 
since there ié evidence that neoplastic tissue has a 
considerable capacity for gluconeogenesis (Kit and Graham, 
1956).
Clinically, the picture is further complicated 
by the apparent ability of many primary tumours to synthesize 
large amounts of substances with hormonal activity, 
simulating hyperfunction of a particular endocrine gland. 
Thus, a wide variety of cancers, particularly hepatic 
and adrenal carcinomas, have been reported in association 
with hypoglycaemia (Lipsett et aJL., 1964; Lowbeer, 1961). 
Pancreatectomy did not reduce hypoglycaemia in a mouse 
bearing a transplanted hepatoma (Silverstein ^  al., I960).
Adrenocortical hyperplasia has been reported in 
patients with malignant tumours occurring in regions 
other than the adrenals or adenohypophysis. The most 
common types of tumour associated with this condition 
are bronchial carcinomas and thymomas (Riggs et al., 1961) 
although similar symptoms have been observed occasionally 
in subjects with tumours of the pancreas, CHS, breast, 
thyroid, prostate and oesophagus. These subjects showed 
increased excretion of 17-ketogenic steroids in the urine - 
and increased cortisol secretion rates (Prunty et , I965)•
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Duoas et aJ. (1962) studied five patients with Cushing’s 
syndrome and non-endocrine tumours, and found significant 
amounts of an ACTH-like substance in the plasma, and in 
extracts of the primary tumours and secondary deposits* 
Evidence of adrenal hyperfunction was abolished by adrenal*!* 
ectomy, suggesting that the condition was due to an excess 
production of corticotrophin-like material and not 
glucocorticoids by the tumour, The high glucocorticoid 
excretion was not abolished by dexamethasone indicating that 
corticotrophin production by the tumour is not under 
negative feedback control, unlike that of the pituitary. 
Whether or not this corticotrophin-like substance is ACTH 
remains to be shown.
Other syndromes which have been reported to result 
from interference with the hormonal control systems of the 
host by paraendocrine tumour activity have been hyper#* 
thyroidism (Tisne al,, 1955; Dowling et al., I960) 
and excessive production of serotonin (Oates and Sjoerdheim, 
1964), gonadotrophin (McArthur, 1963; Hung et al,, 1963), 
anti-diuretic hormone (Schwartz et al•, 1957; Armatruda et 
al,, 1963) and insulin-like factors (Hobbs and Muller, 1966)*.
In animals bearing experimentally transplanted 
tumours, there is evidence that production or utilisation 
of some of the protein anabolic hormones is impaired
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(Goodlad, 1964; Claus et 1962; Bab son, 1954;
Goranson, 1955; Begg, 1955), whilst the levels of protein 
catabolic hormones may be increased. For example, there 
is evidence to suggest that the adrenals of tumour-bearing 
animals may be hyperfunctional, with respect to both 
glucocorticoid and aldosterone production (Begg, 1958;
Hilf e^fc al•, I960; Kavetsky et al•, 1962; Rechcigl et al., 
1961).
The catabolic action of corticosteroids upon protein 
distribution in the tissues of the animal body is in many 
respects similar to that of a growing tumour, in that it 
causes a breakdown of carcass protein and a deposition of 
liver protein (Silber and Porter, 1953; Goodlad and Munro, 
1959). On the other hand, livers of rats bearing a Walker 
256 carcinoma exhibited a much greater increase in ribo­
nucleic acid content relative to protein than did rats 
treated with cortisone (Clark and Goodlad, I960). The 
levels of hepatic alanine alpha-oxoglutarate transaminase 
in hypercortical rats and tumour-bearing rats (Rosen et al., 
1959; Harding ^  âi»> 1961; Beaton ^  âi*> 1957; Goodlad 
and Clark, 1962), do not support the hypothesis that increase 
concentrations of glucocorticoid are responsible for the 
effects of the tumour growth on liver metabolism. Sobel 
(1966) showed that although tumour growth and cortisone
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administration produced a similar loss of protein in rat 
abdominal muscle, the depletions occurred in different 
protein fractions.
Goodlad (1964) has suggested that adrenal hypertrophy 
in rats bearing a Walker 256 carcinoma could be related to 
the level of hepatic A^-steroid hydrogenase activity• This 
suggestion is based on the correlation between the level 
of this enzyme system and adrenal size shown by Urquhart 
(1958), and the observation of an elevation in the 
activity of the enzyme in rats bearing a Walker 256 carcinoma 
(Goodlad and Clark, 1961).
There is little doubt that the levels and possibly 
the action of several hormones are altered in the tumour- 
bearing animal, but the evidence suggests that these 
alterations are due in the main to atrophy or hypertrophy 
of the endocrine glands (Begg, 1958; Goodlad, 1964; Claus 
al., 1962). These effects on the endocrine system could 
result either from the general protein depletion occurring 
in the cancerous animal (Sherman et al., 1950) or to 
paraendocrine activity in the tumour (Lipsett, 1964) , and 
in any event will inevitably contribute to the observed 
effects of tumour growth in the host animal. Nevertheless, 
these effects must be secondary to some primary action of 
the tumour upon the endocrine system, so that the alterations
p
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in host metabolism cannot be attributed solely to 
hormonal imbalance.
(ill) The secretion of a cancer toxin
The idea of a cancer toxin from neoplastic tissue 
is not new (Ewing, 1934), and a diffusible substance produped 
by a tumour has been suggested as a possible explanation of 
the systemic effects of the tumour (Greenstein, 1943).
4dams (1950) demonstrated that the injection of a tumour 
suspension into mice led to an early depression of liver 
catalase activity* The activity then returned to normal, 
with a second drop when the tumour became established.
The effect of tumour growth upon liver catalase activity 
has been discussed above. From this and subsequent experimen 
Adams concluded that tumour tissue contains a factor, 
present in only low or negligible concentrations in normal 
tissue, which produces a fall in liver catalase activity 
when injected into normal animals (Adams,1952; Adams, 1953). 
In 1948, Nakahara and Fukuoka had succeeded in preparing a 
fraction from human tumours, which depressed the activity 
of liver catalase when injected into normal animals*
Nakahara and Fukuoka named this material ’toxohormone’, a 
name which was intended to convey the combination of humoral 
and toxic properties exhibited by the substance (Nakahara
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and Fukuokj, 1948). Greenfield and Meisteic (1951) 
confirmed this work using transplanted tumours in 
experimental animals, namely a mammary tumour in mice, and £ 
fibrosarcoma and the Walker 256 carcinoma in rats.
A detailed account of the development of the 
extraction and purification procédures which eventual3.y led 
to the production of a toxohormone fraction active in doses 
of 10 ug per rat, is given in section 3 (page 107)
An active fraction has been prepared from the 
spleen of healthy mice (Day et , 1954), suggesting that 
toxohormone production may not be confined to tumour 
tissues. However, the catalase depression produced in 
these experiments was relatively small, and did not approach 
the 50^ depression required by Nakahara and Fukuoka (1948). 
Nakahara and Fukuoka (1954) reported the production of 
toxohormone by tumour tissue slices in vitro, when 
incubated with amino-acid mixtures in the presence of 
adenosine triphosphate. Under identical experimental 
conditions, normal tissue slices (liver and skeletal muscle 
failed to produce demonstrable amounts of toxohormone. It 
would seem, therefore, that while toxohormone may be presen 
in small amounts in certain normal tissues, it is produced 
in quentity only by neoplastic tissues.
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The attribution of the depression of liver catalase 
activity to the action of toxohormone requires acceptance 
of the hypothesis of humoral transfer of this agent.
Masamune et ^1* (1958, 1959) isolated glycoprotein 
from the fluids obtained from different tumours, and this 
glycoprotein showed a clear toxohormone effect on liver 
catalase activity. Hirseh and Pfutzer (1953) reported that 
not only the cells, but also the cell-free fluid of Ehrlic%/ 
ascites carcinoma and Yoshida sarcoma were active in 
depressing liver catalase activity when injected into 
normal mice. Gastric juice from patients suffering from 
gastric cancer has also been shown to possess toxohormone 
activity (Kawamorita et_ aJ.., 1951; Iwatsuru ^  al*, 1954).
Nagagawa (1952) reported the isolation of a liver 
catalase depressing factor from the urine of cancer patients, 
by means of benzoic acid adsorption, and the presence of 
toxohormone in urine from cancerous patients has since been 
confirmed by Sato et (1953 ) and Fuchigami et al. ^ (1956).
Lucke et (1952) utilised the method of parabiosis
for the study of the problem. The principle involved is that; 
capillary anastomoses develop at the parabiotic junction, 
through which a small quantity of blood crosses continuously 
between the partners. Lucke included in his experiments
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normal rats, normal parabiotic pairs, rats bearing a Walker 
256 carcinoma, and parabiotic pairs of which one partner 
was t-umour-bearing, Tumours were implanted from six to 
forty-nine days after parabiosis was established, and assays 
made from twelve to eighteen days after implantation showed 
that when one partner was tumour-bearing, the liver catalase 
level was depressed in both animals, the degree of depression 
being approximately the same as in single tumour - bearing 
rats. Parabiosis per se did not affect liver catalaso 
activity. It was thus established that the tumour substance 
responsible for the depression of liver catalase activity 
can be transferred across a parabiotic junction.
Plaza de los Reyes ^  al.(1953) reported that fresh 
plasma of cancer patients reduced liver catalase activity 
when injected into normal rats, and Kuzin ^  aj,. (1955) 
also found that the alcohol precipitable fraction separated 
from the blood of tumour-bearing animals exerted a similar 
effect. ‘ ' 1
On the basis of the above evidence, it can be 
concluded that toxohormone is secreted from the tumour into 
the body fluids of cancer patients and tumour—bearing 
animals•
Several other effects of toxohormone, apart from
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the depression of liver catalase, have now been described 
(frojanowski, 1970), Most of these appear to be concerned 
with iron metabolism, but all of the activities reported 
for toxohormone have also been associated with tumour 
growth# A list of these activities is shown in Table 23 , 
(page 120), and their implications will be assessed in the 
general discussion (page 154) #
The transplantable tumour in cancer research 
(i.) Reservations
Results of various kinds obtained with the use of 
transplanted tumours have been extrapolated more or less 
freely to spontaneous tumours# In recent years, it has 
become increasingly obvious that such inferences are unjustifi 
in certain cases, and that serial transplantation by itself 
may lead to artificial situations, complicated by factors 
which do not enter into autologous tumour-host systems*
The environment of growing neoplastic tissue is 
well-suited to viral growth (Eoprowska and Koprowski, 1953)  ^
which, unlike most instances of bacterial contamination, 
is not obvious to the eye of the researcher, and does not 
lend itself to simple detection# Such viral contaminants 
may or may not damage the tumour cell itself, but in any 
event are likely to complicate the results of experiments
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designed to investigate the growth, ultrastructure or 
biochemistry of tumours $
Klein (1959) pointed out that unless the most 
stringent steps are taken to ensure the genetic identity 
of the dohor and recipient in a transplantation experiment, 
isoantigenic differences are certain to exist between the 
host and the tumour# Because transplantation is usually 
between animals belonging to a highly inbred strain, these 
differences are unlikely to be sufficient to cause rejectin 
of the transplant, but may nevertheless produce reactions 
in the host not attributable to the effects of the tumour 
per se.
There is evidence too that serial transplantation 
itself causes differences in the action of the tumour. 
Greenlees and LePage (1955), studying the uptake of ^^0- 
glycine into tumour proteins during early transplant 
generations of a mammary carcinoma of the mouse, found an 
accumulation of counts in the tumours during starvation 
only after the fifth transplant generation. Kampschmidt 
and Upchurch (1972) followed the alterations produced in 
the host by a sarcoma induced by the intramuscular injection 
of 20-methylcholanthrone, for 60 generations. . They found 
that plasma lactate dehydrogenase activity, the number of
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peripheral blood leukocytes and adrenal weight were increased 
abruptly during early transplant generations, and that tlie 
levels returned ,to near their normal values during the 
later generations of the tumour* Haemoglobin concentration, 
liver catalase activity, plasma iron levels and total iron- 
binding capacity were significantly decreased in rats 
bearing primary tumours and remained at these lowered levels 
throughout all of the transplant generations studied.
It also appears that the site of transplantation of 
the tumour is an important factor in the type of effects 
produced by the tumour. Kampschmidt and Upchurch (1966) 
implanted the Jensen sarcoma, the Walker carcinoma and the 
Novikoff and MDAB hepatomas into a series of rats. Each 
rat received an inoculum of cells from one of these tumours 
either intramuscularly, intraperitoneally or suboutanecusly. 
They found that for each tumour, the intraperitoneal 
transplant grew the most rapidly, produced the largest 
adrenals, smallest thymuses, the lowest total iron-binding 
capacity, and the most severe anaemia. The intramuscular 
transplants caused the most carcass weight loss and the 
greatest lowering of plasma iron and kiver catalase, whilst 
the subcutaneous tumour growth appeared to be associated 
with the most pronounced gains in liver and spleen weight.
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Considerable differences also exist between the 
tumour-host relationships observed during the growth of 
different types of transplantable tumour. The responses of 
several types of tumour to alterations in dietary protein 
intake (Babson, 1954; Hilf, 1956; Yoegtlin and Thompson, 
1949; Green et al., 1950) have already been discussed 
(page 8), and give an indication of the variation which can 
be encountered. Even the very closely related Morris 
hepatomas exhibited considerable diversity in their abiliiy 
to concentrate alpha-aminoisobutyric a#id^ and in the respone 
of the amino-acid transport system to hydrocortisone and 
glucagon treatment (Baril al., 1969).
These results show quite clearly that data obtain^ 
by experiments on animals bearing transplantable tumours 
apply only to one species, one tumour, and one set of 
experimental conditions, and broad generalisations drawn 
from such work should be treated with caution*
(ii) The Walker 256 carci.Q.0sarcoma
The Walker 256 carcinosarcoma originated in the 
mammary gland of a Wistar rat at the Johns Hopkins Hospita,l 
in 1928, and has since been propagated by serial trans­
plantation in many laboratories. It grows as a globular 
mass in epithelial or muscular tissues, and has a cellular
51
peripheral rind and a necrotic central core# Macro8copie 
métastasas and bacterial infection are rarely observed 
under normal circumstances (Earle, 1934). This tumour 
has been used for all the studies described in this work.
Mider (1953) observed that the growth of the Walker 
tumour could be divided into three phases;
1. An initial period of comparatively slow increment in 
mass by both tumour and host.
2* A longer phase of greatly accelerated tumour growth, 
during which host tissues, with the exception of liver 
and spleen, lose weight, and dietary intake declines.
3. A brief final stage when the neoplasm grows little 
if at all, and all of the host tissues lose weight 
very rapidly.
Death may occur late in phase 2 or in phase 3, and the 
host normally dies in the third or fourth week of tumour 
growth,
Scope of the present work
In the present work, the study of the effects of 
the growth of the Walker 256 carcinoma upon some aspects 
of the protein metabolism of rat diaphragm muscle was 
undertaken.
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The first part of the work involved studies on 
the microscopic appearance and protein content of diaphragm 
muscles of tumour-hearing rats, to verify that the depleting 
effects of tumour growth on the carcass (Mider et aJ,, 1948) 
and skeletal muscle (Sherman et al., 1950) did extend to 
the diaphragm muscle.
The cachexia evident in the tissues of the tumour-
bearing host involves depletion of the muscle proteins
(Sherman ^  al., 1950) but it is not known whether this
depletion arises from a decreased synthesis or an increased
catabolism of protein within the muscle. Norberg and
Greenberg (1951) showed that labelled glycine was incorporate
less readily into skeletal muscle protein of mice bearing
the 6 G^H ED tumour than into the proteins of normal mice.
Winnick at al, (1948) had previously found that the uptake
of labelled tyrosine in the tissues of rats with transplanted
tumours was less than that in the control. Both these
studies had been performed in vivo, so that the results
may have been obscured by other tumour effects, such as
those on amino-acid transport (see page 4), In the present
work, diaphragm muscles from normal rats, and from rats
bearing a Walker 256 carcinoma were compared for their
%ability to incorporate 'E-lysine into protein in an in vitro
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incubation system. Variations of the composition and 
concentration of the amino-acids added to the incubation 
medium were tested for possible effects on the relative 
incorporation by the muscles from the healthy and diseased 
animals.
The action of insulin in stimulating protein synthesis 
in diaphragm muscle in the system used has been well-documented 
(Wool, 196?). Although it is known that tumour—bearing 
animals are not diabetic (Begg, 1958), they do show impaired 
glycogen deposition in liver when subjected to a glucose 
test load (Goranson^ 1955; Young et , 1947; GoIdfelder, 
1928), which can be restored to normal by administration of 
insulin (Begg, 1955). This finding could be taken to 
suggest that there is an impairment of production or a 
decreased sensitivity to insulin in the tumour-bearing 
animal, or else that the demands of the tumour for administered 
glucose are so high that the liver is unable to compete 
until the insulin level is raised. The influence of 
insulin administered both in vivo and in vitro upon 
incorporation of isotope into the muscle of normal and 
tumour-bearing animals was tested, to determine if the 
hormone could alleviate the interference of the tumour with 
muscle protein metabolism.
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The systemic effects of toxohormone reported in 
the literature have been largely concerned with iron 
metabolism, but Obara and Ono (1965) reported an inhibitory 
effect upon rat lens and corneal protein synthesis. If 
toxohormone production is an important factor in the mechani.sm 
of action of the tumour, some effect upon protein metabolism 
should be apparent in the muscles of animals treated with 
toxohormone. Accordingly, a toxohormone fraction was 
prepared and purified, and tested for an inhibitory effect 
upon incorporation of labelled amino-acid into the muscle 
protein of healthy animals*
It was hoped that these investigations would throw 
some light upon the mechanisms involved in the action of 
the tumour upon the host’s metabolism, and that the 
involvement of toxohormone in the production of the cachectic 
effect of the tumour might be clarified.
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SECTION 1
trseti
The effect of growth of the Walker 256 
carcinoma on the microscopic appearance, 
water content, extracellular space and protein 
content of diaphragm muscle.
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INTRODUCTION
It-has been nointed out (page 12) that the cachectic 
condition of tumour-bearing rats is most evident in the 
case of skeletal muscle tissue. This section is an account 
of changes observed in the morphology, water and protein 
content of the diaphragm muscle of rats bearing a Walker 
256 carcinoma.
The muscle appeared by eye to be much thinner and more 
transparent in the tumour-bearing rat than in the normal 
animal and was more fragile and liable to damage during 
dissection. In view of these observations, diaphragms 
from healthy and tumour-bearing animals were examined 
microscopically, and an estimate made of muscle fibre 
diameter.
Studies were also carried out on possible alterations 
in extracellular space in diaphragms of tumour-bearing rats. 
In addition, since diaphragm preparations were to be used 
later to study the effect of the tumour on protein synthesis 
using labelled amino-acids, attempts were made to compare 
the accessibility of such preparations to small molecular 
weirht compounds. Extracellular space estimations require
the use of a marker which does not penetrate the nuiscle cell 
membrane. Inulin, a polysaccharide of approximately 5,000 
molecular weight, has been reported as meeting thio require­
ment (Davson, 1964). It is not, however, a suitable
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compound to study the penetration of diaphragm preparations 
by small molecular weight compounds. The sugar alcohol, 
sorbitol, has similar diffusion characteristics to glucose, 
and does not penetrate the intact muscle cell (Î'organ et al., 
1961). Sorbitol was therefore chosen as a low molecular 
weight extracellular marker and also as a molecule to estimate 
the accessibility of diaphragm preparations.
The conditions of incubation of the muscle with the 
marker are critical to the accurate measurement of the extra­
cellular space available to the marker. Sufficient time 
must be allowed for complete equilibration of the marker 
with the extracellular space. Kipnis and Cori (1957) 
found that the initial rate of penetration of inulin was 
lower than that of thiosulphate and raffinose, probably 
reflecting a slower rate of diffusion owing to its larger 
molecular weight and size, /Vfter 2 hours all markers 
tested by Fipnis and Cori gave constant results. Accordingly, 
this was the incubation period selected for these experiments.
The temperature of incubation also appears to be very 
important. Preliminary soaking of rat diaphragm in Krebs- 
Henseleit buffer at 0°G has been reported to result in an 
increased glucose uptake on subsequent incubation at 37<>C 
(Brown et al., 1952) , The same authors report that such 
treatment also results in a 3C^ increase in the extracellular 
space. Incubation at 12°G for periods up to 30 minutes
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caused an average increase of 1 in wet weight, with 
concomitant increases in both extracellular and intra­
cellular volumes, although incubation for the same length 
of time at 17°C did not alter the total water content 
(Brown et , 1952) . In the present work, diaphragms 
were incubated at 20°C as recommended by Kobayashi and 
Yonemura {196?) #
Kipnis and Cori (195^) used two preparations of 
rat diaphragm muscle for their extracellular space 
determinations. These iwsre the ’cut’ or hem id la phragm 
preparation, where the muscle ig excised from the rib- 
cage and bisected, and the ’intact ’ preparation,, where 
the diaphragm is dissected from the animal with all its 
insertions intact. These preparations are described on 
page 44 • Kipnis and Cori showed that the thiosulphate 
space of cut diaphragm incubated in vitro is consistently 
larger than that of the intact diaphragm preparation, and 
concluded that in the former, marker was penetrating the 
cut ends of the muscle cells. Both types of preparation 
were employed in the present work.
The work of Sherman et (1950) indicated th^t 
skeletal muscle as a whole was depleted of protein by 
tumour growth, but did not indicate whether all types of 
muscle were equally sensitive to the effects of the tumour. 
There is evidence that in rats bearing the Walker 256
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carcinoma, the gastrocnemius muscle is depleted to a much 
greater extent than is the soleus (Clark and Goodlad, 1971), 
An investigation was therefore made of the effect of the 
tumour on the total protein and also on the relative amounts 
of contractile, sarcoplasmic and extracellular proteins of 
rat diaphragm.
The solubility characteristics of adult striated 
muscle were investigated by Robinson (1952). The intra­
cellular proteins of adult tissue may be conveniently 
divided into the proteins of the sarcoplasm, such as 
myogen and myoalbumin, including the enzymes of the 
glycol]rtic cycle; and the proteins of the myofibril, 
such as actin and myosin. Extracellularly, connective 
tissue fibres of collagen and elastin ramify throughout 
t he mus c le ( Bat e Smit h, 1937),* Bat e Smith ( 1934,1935) 
demonstrated that up to 05^ of the intracellular protein 
was extracted by strong salt at neutral pH, and that 
subsequent dilution to lower ionic strengths selectively 
precipitated myofibrillar proteins, leaving the sarcoplasmic 
proteins in solution. Robinson (1952) extended this work 
by extracting the muscle with salt solutions of different 
ionic strengths and pH values. He found that a dilute 
KOI buffer at pH 7.1 would extract the sarcoplasmic 
proteins and the myofibrillar protein actomyosin. Acto- 
myosin could be selectively precipitated an ethanol
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concentration of 7^ (v/v) at 0*0. Dilute alkali extracted 
the myofibrillar proteins, leaving only collagen and 
elaStin (Lowry et al., 1941), This procedure was used,
as modified and described by Dickerson (I960), for the 
fractionation of proteins in this work.
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Microscopic examination of diaphragm muscle from normal 
rats and rats bearing a Walker 256 carcinoma,
A healthy rat and a tumour-bearing rat were sacrificed 
by stunning followed by exsanguination, and a section of 
diaphragm muscle, approximately 1 cm^ in area, was excised. 
Figure 1 shows the area of the muscle from which the samples 
were obtained. These muscle sections were rinsed in 
(w/v) NaCl and frozen onto a block of 12,5^ (w/v) gelati.je 
by blasting with CO2, Longitudinal sections of 6 microns 
thickness were cut on a SLEE cryostat, the blade of which 
was maintained at -20°G. The sections were transferred
to microscope slides and fixed for 30 minutes in a 90 : 10 
(v/v) mixture of glacial acetic acid and 90^ (v/v) ethanol^ 
The slides were rinsed three times with 75^ (v/v) ethanol, 
soaked in distilled water and stained with 1<^ (w/v) xylidene 
ponceau - 0.5^ (w/v) acid fuchsin for 2 minutes. The
stain solution was washed off with distilled water and the 
sections dehydrated by successive washings with 96<^ (w/v) 
ethanol and absolute ethanol. Finally the slides were 
cleared with xylol before mounting in styrene. The sections 
were viewed under a Zeiss photographic microscope, and 
representative fields from each section photographed.
The mean diameter of fibres from muscles from normal 
and tumour-bearing animals was estimated using the vernier 
attachment on the microscope. 3 sections from each type
FIGURE 1
Abdominal surfoce of the diaphragm muscle. The shaded region shows the area of the muscle studied in the microscopy experiments «
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of muscle were examined, and within each section the width 
of 12 groups of 5 neighbouring fibres was measured, in 
randomly selected fields.
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Measurement of the extracellular space of diaphragm muscle 
from normal rats and rats bearing a Walker 256 carcinoma
Preparation of animals
Kale Wistar rats, weighing between 175-22 5 g,, were 
used throughout this work. Animals were housed individually 
and fed a diet of a paste of 12 g, freshly-ground rat-cake 
(North Eastern Agricultural Co-operative Ltd.), moistened 
with water, given daily at 5 p.m. Water was given ad 
Ubitum throughout the experimental period. The animals 
were starved for 24 hours before commencing their diet, and 
their initial body weight noted.
A rat bearing a large Walker 256 carcinoma was killed 
by chloroform/ether anaesthesia. A portion of the rapidly- 
dividing tumour cortex was quickly excised and gently 
homogenised in an all-glass Potter homogeniser (Potter and 
Elvehjem, 1936), with 5 ml. of a sterile solution of 0.9^
(w/v) NaCl and 1^ (w/v) glucose. An 0.5 ml. aliquot of 
this homogenate was injected subcutaneously and aaeptically 
into a shaved area on the side of the rat. It was found 
that the tumours took from ten to fourteen days to reach 
20-40 g. Tumours grown from cells of the same donor tumour 
normally attained approximately^ the same size in different 
rats.
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Dissection of musc-les
Two muscle preparations were used in this work - the 
intact diapliragm preparation of Kipnis and Cori (1957) and 
the  ^cut ^ diaphragm preparation, described by Manchester 
and Young (1958).
The intact diaphragm preparation was accomplished as 
follows: the sternum was divided horizontally at the level
of the fourth costal cartilage, after which the ribs were 
transected superior to the insertions of the diaphragm. 
After the attachments of the abdominal and back muscles 
had been cut from the lower rib-cage, and the intrathoracic 
and abdominal structures adhering to or traversing the 
central tendon had been severed, the diaphragm was freed 
by transecting the spine above and below the twelfth 
vertebra. The insertions of the diaphragm to the xiphoid 
process, ribs, central tendon and spine were maintained, 
and the diaphragm thus prepared exhibited integrity of all 
its muscle fibres (Kipnis and Cori, 1957). Figure 2 
shows the points of incision for this preparation.
In the dissection of the ^out^ diaphragm, the rats 
were killed bv stunning followed by exsanguination. The 
diaphragm was rapidly excised from the rib-cage and 
transferred immediately to a Petri-dish containing ice-cold 
Krebs-Henseleit bicarbonate buffer (Krebs and Henseleit, 
1932) (see page 45 ). Excess tendon and anv adhering
(a)
xiphioid
cortitage
xiphisternum
liver
(b)
bronchus
5
hear
pung 
phrenic n.
diaphragm
Fiyre 2./a; Dotted line shows the rib-cage incision made in the 
preparation of the intact diaphragm.
(b) View of the intrathoracic adhesions to diaphragm.
I.V.C. - inferior vena cava.
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lung and liver tissue was trimmed ofi and the lateral 
and dorsal slips removed. The hemidiaphragms were then 
obtained by carefully cutting along the outer boundaries 
of the central tendon.
Determination of the inulin and sorbitol spaces of diaphragm 
muscle from normal rats and rats bearing a Walker 256 
carcinoma
Animals were prepared as detailed on page 43 and the 
hemidiaphragns or intact diaphragms were excised. Krebs- 
Henseleit bicarbonate buffer pH 7.4 (Krebs and Henseleit, 
1932) formed the basis of the incubation medium, used with 
both extracellular markers.
This buffer was prepared from the following six stock 
solutions :
(1) 0,9^ ,(w/v) NaCl; (2) 1J5^(vr/v) KOI; (3) 1,22'^ (w/v) 
CaCla; (4) 3.03/.(w/v) FgSO^; (5) 2.11^ (w/v) KH2PO4;
(6) 1.30jC(w/v) NaHCOg.
Solution (6) was prepared fresh evei-y day and gassed with 
CO2 for 1 hour before use. The six stock solutions were 
mixed in the correct proportions immediately before the 
medium was required, the requisite amounts being:
100 volumes (1) : 4 vols. (2) : 1.5 vols. (3) : 1 vol. (4) : 
1 vol. (5) : 17.5 vols. (6),
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The complete mecLram was gassed for 15 minutes with a
95:5 (v/v) mixture of 0 ;C0 , and extracellular marker2 2added to make the final medium (w/v) with respect to 
the marker.
For the determination of the inulin space of hemi­
diaphragms, the muscles were soaked in 5 ml. of the inulin 
medium for 2 hours at a temperature of 2â°G, in which time 
the inulin was considered to have diffused into the extra.- 
cellular space (Kipnis and Cori, 1957). The muscles were 
then removed, blotted gently to remove any inulin-containing 
solution from the surface of the muscle, and soaked for 
another 2 hours in 5 ml. of inulin-free Krebs-Henseleit 
buffer. In this time the inulin contained in the extra­
cellular space should diffuse into the inulin-free buffer 
(Kobayashi and Yonemura, 19&7),
The amount of inulin which had diffused out into the 
inulin-free solution was measured spectrophotometrically, 
utilising a diphenylamine colour reaction (Harricon, 19A2). 
Diphoriylamine reagent was prepared by dissolving 3 g. 
diphenylamine in 100 ml. glacial acetic acid. 60 ml, 
concentrated HCl was added to this solution, end the 
resultant reagent could be stored at 6°C for 1 month in an 
amber bottle. The best solution was diluted to be within 
the concentration range of 2 - 12 ug, inulin/ml. 2 ml, 
of the test solution were mixed with 4 ml, diphenylamine 
reap^ ent and incubated at 100°C for 30 minutes, Inulin is
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a polysaccharide composed of fructose, and the hydrolysis 
with the concentrated acid of the diphenylamine reagent has 
the effect of breaking the molecule down to its consistent 
sugars, which are capable of reacting with the diphenylamine 
to form a colour complex. The extinction produced by the 
colour complex was measured at 620 nm, and the concentration 
of inulin in the test solution estimated from a standard 
curve, shown in Figure 3,
A tissue blank value was obtained by incubating a 
muscle in inulin-free medium for 2 hours, and transferring 
to fresh inulin-free medium as described above. The total
water content was determined by heating to constant weight 
at 110° G, The extracellular space could then be calculated
according to the formula;
Extracellular space N 1- X - X 100total water content) 1 ^
where
N S» ug inulin diffused out from muscle
I initial concentration of inulin in incubâtiou modivim 
expressed in ug/ul.
W - total water content of muscle in ul.
In the case of the sorbitol space determination, 
14c-U-sorbitol, 6.7uCi/imol. (Radiochemical Centre, Amersham) 
waw ii.cip.d a.q the extracellular marker. The specific activity
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I* Standard ourve for the eat donation of inulin "by the diphenylamine method (Harrison^  1942).
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of the mediuffi was adjusted to 0.1 uCx/m.l, After the 
2 hour incubation the muscles were blotted gently and 
immersed in boiling water for 15 minutes, during which 
time all the small molecular weight components of the 
muscle were assumed to have been extracted (Battaglia and 
Randle, I96O). The muscle was removed, the water allowed 
to cool, and the volume adjusted to exactly 5 ml. 0,1 ml. 
aliquots were counted in 5 ml. 220 scintillation cocktail
(Nuclear Enterprises. Edinburgh). The radioactivity of the 
medium was similarly assayed, and the total water content of 
the muscle estimated by heating to constant weight at 110°0. 
The sorbitol space of the muscle was calculated bv application 
of the formula:
Extracellular space N 1- — X ^ X 100(^  total water content) I
where
N =» counts/minute in boiling water extract 
I =» count 8 / minut e/ micro 1 it re in incubation medium 
W =» total water content of muscle in microlitres.
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Isolation and estimation of proteins from diaphragm muscle 
of normal rats and rats bearing a Walker 2 56 carcinoma
Isolation of total intracellular protein
Frozen muscles were minced finely with scissors and 
homogenised in 2 ml, 0.3N NaOH with a tightly fitting motor- 
driven pestle, at O^G, The homogenate was centrifuged at 
600g. for 15 mins, at 2^0, The residue was’ rehomogenised 
twice, the supernatants being collected by centrifugation. 
The final homogenate was allowed to stand for 12 hours at 
2‘^G before centrifugation. The residue, consisting of 
collagen and other metabolicaUy inert proteins (Robinson^ 
1952)# was discarded. A ha If-volume of 3 W  (w/v) trichlor­
acetic acid (TCA) was added to the collected supernatants, 
and the precipitate allowed to stand for 30 minutes at 2®C, 
before collection by centrifugation at 600g for 15 mins. 
at 2^0. The protein was washed six times by suspension 
and centrifugation with 5 ml. 10^ (w/v) TCA to remove any 
residual non-protein-bound nitrogenous material, twice with 
ethanol to remove TCA and water, and finally, once with 
ether to remove the ethanol. The proteins were dried and 
stored under vacuum.
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Isolation of sarcoplasmic, myofibrillarand residual proteins
The flow chart of this extraction method is shown in 
Figure 4, The frozen muscles were minced finely and homo­
genised at 0("C with 1 ml. fdilute salt ^ solution, which 
consisted of 0.066M NaH2P0/^: K2HPO4; 0,1M KGl; pH 7.1 
I 0.2 (Dickerson, 1960). The homogenate was centrifuged 
for 15 mins. at 600g, at 0®C, the extraction with dilute 
salt solution repeated twice and the supernatant pooled.
One haIf-volume of 30^ (v/v) ethanol was added to the 
collected supernatants, and theaallowed to stand overnight 
at 0®C to precipitate actomyosin.
The residue from the dilute salt extractions was 
homogenised three times with 0.1N NaOH, the supernatants 
being collected by centrifugation. The final homogenate 
was left to stand for 12 hours at 2^0 before centrifugation.
Proteins in all fractions were precipitated by the 
addition of one half-volume of 50^ (w/v) TCA and washed and 
dried in the manner described on page 49 for the total 
proteins.
Estimation of muscle proteins
Dried muscle protein fractions prepared as described 
in the previous two sections were redissolved in 0.3N NaOH
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and estimated bv the Lowry method (Lowry et al., I951 ) ,
A. standard -curve is shown in Figure 5. The residual 
protein fraction, being insoluble in 0.3N NaOH, was 
dissolved in nitrogenr-free concentrated sulphuric acid, 
and estimated by micro-kjeIdahl nitrogen (Ma and Zuazaga,
1945) .
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Figure_5* Staiidazxi curve for the estimation of muscle pro teins by the Lov/xy method (Lowry _al., 1951)* A solution of mixed muscle proteins was estimated by the microkjedahl nitrogen method, and subsequently used 
as a standard nrotein solution#
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Figure 4 Fractionation procedure for muscle protein
Muscle
Extraction with ^dilute salt^ solution x 3 at O^C
Supernatant Residue
Precipitation with 30^(v/v) ethanol at O^G
Centrifugation at600g#
Extraction with 0\f1N 'mOH X 3at 0'® C
Gentnifugat ion
Supernatant rA ct omyos in .Supernatant
Pre c ipitation with 3CK (w/v.) TCAX^ Residual■"'protein’s
P r e c ip ita t io n  w ith  3#(W/v) TCA
(Washing T6 TCA., X2 ethanol.)X1 ether }
/
Sarcoplasmic proteins lypf ibr lllar, prot e ins
* trichkoracetic acid
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RESULTS AND DISCUSSION
The microscopic appearance of diaphragm muscle from normal 
rats and rats bearing a Walker 256 carcinoma
Plate 1 shows a typical field from a section of diaphragm 
muscle taken from a normal rat, whilst Plate 2 shows a field . 
from a section of diaphragm muscle excised from a rat bearing 
a Walker 256 carcinoma. The magnification of both of these 
fields is x 100,
The fibres in the muscle from the tumour-bearing animal 
appear noticeably thinner than do the fibres from the normal 
rat, and this observation was borne out by the figures 
obtained for the mean diameter of the fibres from the two 
types of muscles. The results shown in Table 1 indicate 
that there is a highly significant decrease in the mean 
diameter of fibres from diaphragm muscle of tumour-bearing 
rats.
These figures for the mean fibre diameter are valuable 
only for comparison of the muscles from control and tumour- 
bearing animals and do not represent a true value for the 
diameter of the fibres. Since the sections were cut longi­
tudinally, only a small proportion of the fibres will have 
been cut along the centre, showfng their true diameter.
The remainder, cut either above or below the centre line 
of the fibre, will appear to be smaller than their true 
diameter. Ideally, fibre diameter should be measured on
PLATE 1
Photomicrograph of a section of diaphragm muscle froma normal rat•Magnif icat1on was x 100
PLATE 2
Photomicrograph of a section of diaphragm muscle from a rat bearing a Walker 256 carcinoma.Magnification was x 100

54
a transverse section of the muscle, but the diaphragm does 
not lend itself well to this type of sectioning because of 
its very small cross-sectional area.
However, the value obtained for the control muscle is 
in close agreement with the mean diameter of 2? microns 
reported for the red muscle fibres, which constitutes 
of the fibre population of adult rat diaphragm (Gauthier, 
1969; Gauthier and Padykula, I966; (Padykula and Gauthier,
1963).
55
Table 1
The effect of the Walker 256 carcinoma upon the mean 
fibre diameter of rat diaphragm muscle
Mean fibre diameter in microns
Control Tumour-bearing
2Ô.59 - 0.83=^  22,66 ± 0.59
< 0.01
'Î' Results are expressed as the mean - S.E, of 
56 measurements,
):(>:< In this and the following tables in this section, 
P refers to the statistical sign if loanee of the 
differences between control and tumour-bearing 
rats, as estimated by Student^s t-test.
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The determination of the inulin and sorbit>.)l spaces of 
diaphragm muscle from normal rats and rats bearing a 
Walker 2$6 carcinoma
The results obtained from this series of experiments 
are shown in Table 2.
Table 2
The effect of the Walker 256 carcinoma upon the extra­
cellular space of rat diaphragm muscle.
Musclepreparation
Extra­cellularmarker
Hemidia phragm Sorbitol
Intact diaphragm Sorbitol
Hemid ia phragm Inulin
Extracellular space total water content)!
Conbrol 
63.6±1.93 
21.8±1.65 
40,3±1.66
Tumour-bearing
P !
66.5i2.17 h.s.j 
23.3±1.35 in.s. 
23.4^1.09 k>.Ol!
Results are expressed as the mean  ^8.E, of 12 rats 
except for the data on the sorbitol space of intact 
diaphragm, where the results are the mean - S,E, of 
4 rats.
The total water content of the intact diaphragm préparâtion 
and the hemidiaphragm preparation from both normal and tumour- 
bearing animals was estimated in the course of these experiments, 
and Table 5 shows the data obtained.
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Table 3
The effect of the Walker 256 carcinoma upon the water 
content of rat diaphragm muscle
Musclepreparation
Hemid ia phragm 
Intacb diaphragm
Total water content (ml per g wet weight muscle) p
Control Tumour-b ear ing
78,9-1 76,2±0.6 n.s.
77.6±2.2>K* 74.#3,1 n.s.
Results are expressed as mean - S,E, of 24 rats 
Results are expressed as mean i S,E, of 4 rats
These results do not s^ '^ow any significant differences 
between the total water contents of diaphragms from normal 
and tumour-bearing rats. This indicates that the diaphragm, 
muscle does not share in the general carcass increase in 
water content demonstrated by Haven et al., (I96I),
Published values for the extracellular space of diaphragm 
muscle vary considerably, and some of these are shown in 
Table 4.
From, the figures shown it would appear that there is 
considerable penetration of the cut diaphragm preparation 
by both large and small extracellular markers, almost 
certainly via the cut ends of the fibres (Fipnis and Cori,
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1957; Arvill and Ahren, 1966).
In the present work when sorbitol was used as a marker, 
the values obtained for both hemidiaphragm and intact 
diaphragm preparations were in close agreement with the 
published values (Tables 2 & 4), Furthermore, no differ­
ences were observed between the sorbitol spaces measured in 
the muscle preparations from normal and tumour-bearing 
animals, indicating that the muscle preparations in both 
cases have a similar extracellular space, and also that 
small molecular weight compounds have equal access to the 
muscle cells of the diaphragm preparations in normal and 
tumour-bearing rats.
Table 4
Some published values for the extracellular space of diaphragm preparations in vitro
Source Musclepreparation Extracellular marker
Extra- Î cellular space
Kipnis and Gori(1957) 
ibid, 
ibid, 
ibid.
Hemidiaphragm 
Hemid ia phr a gn l 
Hemid ia phr agn i 
Intact
Arvill and Ahren(1966) Intact
Inulin 53
raffinose 64
thiosulphate 62
thiosulphate 25
inulin 24
All extracellular space values have been expressed as 
^ total water content.
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The results obtained for the inulin space of hemid ia phragms 
appeared anomalous, in that the space in the muscle from the 
tumour-bearing animal was found to be less than the 
space in the muscle from the normal rat (Table 2), If the 
true extracellular space of diaphragm muscle is approximately 
25^ , aa evidenced by the figures presented in Tables 2 and 4 
for intact diaphragm, then the larger apparent inulin spaces 
found with hemidiaphragms from normal rats must be due to 
penetration of the inulin to the inside of the muscle cell, 
probably through the cut ends of the fibres. In order for 
the inulin space of the hemidiaphragm from the tumour-bearing 
animal to be lower than that of the normal animal, the marker 
must either be failing to reach the inside of the cell or be 
failing to penetrate the extracellular space of the muscle.
It would seem unlikely that the cut ends of the fibres in 
the hemidiaphragm from the tumour-bearing animal could be so 
much smaller than those in the normal animal as to prohibit 
the entry of a relatively small molecular weight compound 
such as inulin. It has been shown that protein poly­
saccharide or hyaluronic acid solutions possess a measurable 
exclusion volume to molecules such as haemoglobin and serum 
albumin, but not to small molecular weight compounds 
(Laurent, I9665 Schubert & Hamerman, I96S). These findings 
can be extended to connective tissue matrices in general 
(Gerber &. Schubert, 1964). It could be envisaged that a 
proliferation or reorganisation of the connective tissue 
components of muscle, induced by the cancerous state of
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the animal, might cause exclusion of a polysaccharide 
molecule such as inulin, whilst allowing free access to 
smaller markers such as sorbitol and raffinose. If this 
is the case, then the inulin space of the intact diaphragm 
from the tumour-bearing animal should be very small. 
Measurement of the inulin space of intact diaphragm is not 
feasible using a spectrophotometric method for the estimation 
of inulin. By its nature, the intact diaphragm preparation 
has present a large amount of extraneous tissue, such as 
costal cartilage, which releases diphenylamine-positive 
substances under the conditions of the extracellular space 
determination. The estimation could be performed success­
fully using suitably labelled inulin, such as inulin 
(Marlow and Sheppard, 1971).
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The protein content of diaphragm muscle from normal rats 
and rate bearing a Walker.256 carcinoma
Table 5 shows that the diaphragm muscle lost weip-ht in 
the tumour-bearing animal, and that the total protein content 
of the diaphragm muscle was significantly reduced.
Table 5■II»' mu,.'
The effect of the Walker 256 carcinoma upon the size and 
protein content of rat diaphragm muscle.
Control Tumôûr- P
vrt diaphragm (wet weight in g) per 100 g initial body weight + * 0.308-0,154
1
0.234±0.146l<0.01
mg total protein per diaphragm per 100 g initial body weight 59.40:^3.20 44.0â±3i45 <0.01
mg myofibrillar protein per diaphragm per 100 g initial body weight 3A.70±2.14 27.15^2.13 <0.01
mg sarcoplasmic protein per diaphragm per 100 g initial body weight 15.60±0,7â 12.12io.95 <0.01
mg residual protein per diaphragm per 100 g initial body weight 5.âiio.6o1 . . .. . .
3.9li0.ô2
.... .... .
n.s.
* Results are expressed as mean - S.E. of six rats,
On separation of the proteins of the diaphragm into 
myofibrillar, sarcoplasmic and residual fractions, it was found 
that in tumour-bearing rats the total amounts of myofibrillar
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and sarcoplasmic proteins were significantly decreased, 
while there was no significant alteration In the quantities 
of residual protein.
It can be seen from Table 6 that no significant 
differences were found in the amounts of the protein fractions 
per g muscle in the presence of the tumour.
Table 6
The effect of the Walker 2 56 carcinoma upon the amounts of 
the protein fractions in rat diaphragm muscle.
1 Tumour- Control bearing P
mg total protein per g wet weight diaphragm 195.5-1.7 190.2i6.4 n.s.
mg myofibrillar protein per g wet weight diaphragm 127.5-2.4 116.6±4,5 n.s.
mg sarcoplasmic protein per g wet weight diaphragm 49.4-1.0 52.3±1.9 n.s.
mg residual protein per | g wet weight diaphragm i 20.0-0.9
____________ _______ _ ______ ____ L.-....-.. ..
1 21.2±0.71 n.s.
* Results are expressed as the mean - S.E. of six rats.
It is interesting to note that while the amount of 
myofibrillar protein was slightly reduced in the diaphragm 
from the tumour-bearing rat, the amount of sarcoplasmic 
protein was slightly increased. This tendency was reflected 
in the figures given in Table 7, which shows the relative 
amounts of the three protein fractions.
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Table 7
The effect of the Walker 256 carcinoma upon the relative amounts 
of myofibrillar, sarcoplasmic and residual proteins in 
rat diaphragm muscle.
mg protein per 100 mg total protein
Sarcopiasmic myofibrillar residual
Control
Tumour-bearing 
P
25.27-0,75
27.k^-0,kZ
<0.01
64,^9^0.40
61.51-0, 
<0.01
10.30-0.34
10.6#0.3C
n.s.
^ Results are expressed as mean ts,E. of 6 rats
Thus it would appear that a general depletion of proteins 
occurs in the diaphragm muscle during the growth of the tumour., 
paralleling the loss in weight of the muscle. The data in 
Table 7, showing a significant decrease in the amount of 
myofibrillar protein in the tumour-bearing animal, with an 
increase in the amount of sarcoplasmic protein, indicates 
that there is a tendency for the contractile proteins of the 
muscle to be most affected. The residual or extracellular 
proteins are the least depleted. These findings are in 
agreement with those of Clark and Goodlad (1971), who showed 
that the total amount of myofibrillar protein per gastroc­
nemius muscle was significantly reduced in animals bearing 
a Walker 256 carcinoma. The total amounts of sarcoplasmic
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and extracellular proteins were unaltered.
The diaphragm muscle in the rat and other small 
mammals consists of predominantly red muscle fibres.
The finding of marked depletion of protein in this muscle 
in the tumour-bearing rat is therefore of interest in view 
of the fact that the soleus muscle, which is also a 
predominantly r^ed^  muscle, is relatively resistant to 
the depleting effects of the tumour (Clark and Goodlad, 
1971). However, despite its high proportion of red 
fibres, the diaphragm differs from other such muscles 
in that it cannot be classed as a slow contracting muscle. 
Its speed of contraction appears intermediate between 
that of r^ed^  and ^white^ muscles (Ritchie, 1954; Miledi 
and Slater, 1969)♦ It is also unusual in that it has a 
low innervation ratio (number of contractile fibres/jiumber 
of innervating motor neurons), 25, instead of the normal 
100 - 1000 (Wuerker et al., 1965; Clark, 1931).
Thus the extent to which the muscle responds to the 
tumour is not simply dependent upon its fibre composition, 
even though the rate of protein synthesis in red and white 
muscle fibres is markedly different in the normal animal 
(Goldberg, 1967; Beatty et al., 1963),
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SECTION 2
The effect of the grovzth of the Walker 256 
carcinoma upon the uptake of lysine into 
the protein of rat diaphragm muscle.
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INTRODUCTION
Attention has already been drawn to the fact that 
the wasting of body tissues is one of the most obvious 
physical effects on a host animal of thé growth of a 
tumour such as the Walker 256 carcinoma. Sherman et al. 
(1950) found that most of the tissues which relinquish 
protein during the course of simple caloric starvation 
also yield up a fraction of their nitrogen during the 
period of tumour growth. They further showed that 
quantitatively the most important contribution of protein 
precursors for utilisation by the tumour was made by 
skeletal muscle. Results in the present work (Section 1) 
have indicated that diaphragm muscle proteins are depleted 
in the tumour-bearing animal^ This depletion could result 
from a decrease in the rate of protein synthesis within 
the muscle, or from an increase in the rate of protein 
catabolism, or from a combination of these two effects.
This section describes experiments designed to investigate 
the comparative rates of incorporation of a radioactively 
labelled amino-acid into diaphragm muscle protein from normal 
and tumour-bearing rats.
There are advantages attached to performing ±n vitro 
experiments such as those described in this section, the 
principal one being that the labelled amino-acid has free 
access to the muscle cell, and does not have to pass through
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the liver and plasma of the animal, thereby avoiding to 
a large extent the isotope re-utilisation and dilution 
inevitable under iu vivo conditions. Further, when testing 
the action of a hormone such as insulin, the possibility 
of the effect being masked or enhanced by secondary 
metabolic interactions is eliminated.
Arvill and Ahren (1966) laid down that a tissue 
preparation suitable for the to vitro study of transport 
phenomena through the cell membrane must fulfil at least 
the following two conditions: the relation between the
surface area and tissue mass must be such that good 
diffusion properties between the incubation medium and 
the extracellular fluid of the whole preparation are 
obtained; and it must also be possible to dissect out 
and incubate the preparation with intact and undamaged 
cells. It was recognised at an early stage that the 
rat diaphragm is sufficiently thin to fulfil the first 
of these conditions, and this muscle has been widely used 
for to vitro work. This muscle was first introduced as 
the hemi-diaphragm preparation (Meyerhof et al. 1925; 
Takane, 1926; Gemmill, 1940), This cut diaphragm 
preparation develops an abnormally large extracellular 
space in vitro (see Section 1) , and its permeability to 
ions, carbohydrates and amino-acids ia markedly changed 
as compared to the tissue to vivo (Norman et ai.., 19595
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Menozzi et al., 1959; Kipnis, 1959). Kipnis and Cori 
(1957) described a technique for the dissection of an 
intact diaphragm preparation (see Section 1) which fulfils 
both the above-mentioned requirements for an to vitro 
system.
Although the validity of the first requirement laid 
down by Arvill and Ahren (1966) remains unquestioned, 
experiments using intact or cut diaphragm preparations 
have given similar results with respect to amino acid 
uptake into protein under a variety of conditions.
Both these preparations have been used widely in studies 
on protein synthesis since Sinex et al., (1952) reported 
a stimulatory effect of insulin upon the incorporation 
of "^ 4c from carboxyl-labelled alanine into diaphragm 
muscle protein to vitro,
Manchester (1966) studied the effects of various 
factors Upon the response of diaphragm muscle to insulin. 
He showed that incorporation of 14C-glycine was less in 
the intact diaphragm preparation than in the hemidiaphragm 
preparation. This finding he attributed to the fact that 
accumulation of glycine occurs more slowly in the former 
preparation (Kipnis and Noall, 1958; Manchester and 
Young, i960). On the other hand, the incorporation of 
leucine and phenylalanine, the rates of accumulation of 
which are more comparable in the two preparations
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(Manchester and Young, I96O), is less in the isolated 
hemidiaphragm, i.e. the damaged preparecion, than in the 
rib-cage preparation. This trend is perhaps the more 
normalj  fcr the cutting of diaphragm into strips and small 
pieces was shown by Manchester (I966) to lead to a 
substantial diminution in the capacity of the muscle to 
incorporate àmino-acide. As the tissue becomes increasingly 
damaged, the capacity to respond to insulin is also 
progressively lost, and this is in conformity with the 
generally held view that to vitro actions of insulin 
cannot be readily detected in homogenates (Handler, 1962). 
Hendler (1962) has suggested that protein synthesis near 
the membrane may be a significant proportion of the total 
synthetic activity in muscle. If so, physical damage 
to the membranes may be the chief factor involved in the 
diminution of incorporation when the tissue is cut up. 
Manchester and Young (196O) studied the rate of penetration 
into isolated rat diaphragm preparations of certain 
%  G-amino-acids, and the effect of insulin upon this rate.
No important differences between the behaviour of cut and 
intact preparations was observed. With several amino- 
acids, including lysine, the amino-acid used in the 
present studies, the ratio of concentration of radioactivity 
in tissue water to that to the medium was greater than unity, 
indicating the involvement of some form of active transport
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mechanism. These workers noted also that the addition of 
inoQlin to the medium significantly raised the ratio for 
glycine and CX-amino is obutyric acid, but hot for any of 
the other amino-acids studied. Thus it was concluded that 
the action of the hormone in increasing muscle protein 
synthesis was not due to its increasing the uptake of 
amino-acids.
The results obtained in the present work (Section 1), 
while confirming that the extracellular space of the hemi­
diaphragm preparation is abnormally large, show that there 
is no difference in the space available to small molecules 
in the muscles from normal and tumour-bearing animals.
In view of the proven competence of the hemi-diaphragm 
preparation for to vitro studies of amino-acid incorporation, 
this preparation was largely employed in the present work, 
although some initial experiments were carried out using 
intact diaphragm.
The work of Manchester (I966) showed that the choice 
of incubation medium is highly significant with regard to 
the results obtained in to vitro studies with diaphragm 
muscle. Battacharya (1959&,b, I96I) found that replacement 
of much of the normal ionic composition of the incubation 
medium for diaphragm with sucrose interfered with the 
stimulation by insulin of glucose uptake. Mg^ "*" appeared 
to possess a unique role in the preservation of sensitivity 
to insulin.
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Manchester ( 1966) tested the effect of the alteration 
of the ionic composition of the incubation medium on 
the incorporation of 4c-glycine into the protein of 
isolated rat diaphragm, and the stimulation of this 
process by insulin. He found that there was little 
difference in either the incorporation of labelled 
amino-acid or in the sensitivity of the incorporation 
to stimulation by insulin, using either of the three 
commonly employed incubation media - namely Krebs-Ringer 
phosphate buffer, Krebs-^Henseleit bicarbonate buffer 
(Krebs and Henseleit, 1932) , or Stadie-Zapp buffer 
(Stadie and Zapp, 1947)# It was found, however, that 
swelling or shrinkage of the muscle during incubation 
was minimised by the use of Krebs-H enseleit bicarbonate 
buffer, and this was the incubation medium employed 
throughout the present series of experiments,
Sinex et a^, (1952) found that the transfer of 
from 1-^4c-alanine into protein of diaphragm muscle 
incubated to vitro was less if glucose or pyruvate were 
present in the medium when no insulin had been added, 
and that in the presence of glucose or pyruvate addition 
of insulin raised the incorporation of radioactive amino- 
acid into the muscle protein by only a very small amount. 
On the other hand, Krahl (1953) observed that the to vitro 
incorporation of 14c from 1-Hc-glyctoe into protein of
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diaphragms of normal fasting rats was raised by the 
addition of glucose to the medium, the presence of 
insulin in the medium in addition to glucose having no 
significant effect. Manchester and Young (1958) 
confirmed the finding of Sinex et al, (1952), and 
extended the data to include several other amino-acids, 
including lysine. In view of these findings no 
oxidisable substrate was added to the media used in the 
experiments described in this section,
Radioactively-labelled muscle proteins were counted 
as a solid suspension in a scintillator gel. This 
method was employed because of the tendency of an 
alkaline solution of muscle proteins to cause gradual 
precipitation in the scintillator fluid, producing a 
fall in the counting-rate of the sample. The earliest 
report of the use of suspension counting was that of 
Hayes et al„ (1956) , who resorted to the simple procedure 
of dispersing finely divided solids in the scintillator, 
and correcting for the loss of efficiency as the radio­
active material settled. This method was obviously 
unsatisfactory where large numbers of samples were 
involved and Punt (1956) reported a method for prevention 
of settling by gelatim. He utilised the thixotropic 
properties of aluminium soap solutions, described by 
Sheffer (1948), and showed that these properties extend
75
to the formation of gels in scintillation fluids. The 
mixing of 5^  (w/v) aluminium stearate into a normal 
toluene or xylene based liquid scintillator solution 
produced a colloidal solution which gelled on heating 
to 70°C. With a 137Cs source, a pulse height of 60^ 
of that of the original scintillator solution was 
obtained. The gels were completely transparent and 
colourless, and exhibited the fluorescence properties 
of the original scintillator solution. Radioactive 
material could be incorporated in the gel without 
appreciable settling, and it has been shown that the 
count-rate of such a radioactive sample remains constant 
over a period of several weeks (White and Helf, 1956).
This type of method has since been shown to give 
reliable and reproducible results with the more energetic 
P -emitters (Greene, 1970). Tritium labelled samples, 
as used in the work, can also be counted, but a great 
deal of care in sample preparation is required. This 
is due to the relatively low energy of tritium emissions. 
The energy of the mean tritium beta emission is 9 keV, 
which corresponds to a range of 0.5 microns in media 
with a specific density of 1 (Cleaver, 1967). Particles 
produced for suspension counting techniques are generally 
several microns in diameter, go that only those 
particles emitted near the interface of the radioactive
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material and the fluor will cause photon emission..
For a tritiated material of given sper.ific activity, 
the count-rate would be a function of the surface area. 
Any technique used for sample preparation must, therefore 
ensure that the particle size produced in different 
samples does not vary.
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EXPERIMENTAL
Scintillation counting of muscle proteins
Muscle proteins were counted in suspension using 
a scintillator gel. The size of the protein particles 
had to be such that the final preparation would suspend 
easily and uniformly, and so that the problem of self­
absorption, especially important in the case of tritium 
labelling, would be minimised. This was achieved by 
the use of an agate ba11-mill (RIIC Ltd., London), 
shown in Plates 5 and 4 . The scintillator chosen 
was the commercially available NE 210 (Nuclear 
Enterprises, Sighthill, Edinburgh), which is a standard 
toluene-based scintillation cocktail, with a heat-gelling 
agent added.
The length of milling-time required to reduce the 
overall particle size to one below which the specific 
activity of the sample was constant, was determined. 
Successive portions of the same protein sample were 
treated in the agate ball-mill for increasing periods 
of time, and the specific activities of the resulting 
powders were plotted against milling-time. The 
resultant graph, displayed in Figure 6, shows that a 
plateau, indicating a constant minimum particle size,
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was reached after ten minutes^ This time was employed 
in all subsequent preparations. The optimum amount of 
protein which should be added to each scintillator vial 
was found by counting increasing amounts of a protein 
sample which had been milled for ten minutes. Counting 
rate was then plotted against weight of protein counted, 
and Figure 7 shows that linear conditions obtain up to 
a sample weight of 10*12 mg, after which the count-rate 
of the protein is not proportional to the amount. All 
samples counted subsequently weighed less than 10 mg*
In view of the small quantities of sarcoplasmic 
protein sometimes obtained from hemid ia phragms, the 
reproducibility of the method in counting samples of 
this magnitude was tested. Three samples of the same 
preparation of sarcoplasmic protein, each weighing less 
than 2 mg*, were separately milled, weighed and counted, 
T able 8 shows that the agreement obtained between the 
three values falls within an acceptable range of error.
Table 8
Weight of sarcoplasmic protein counted (mg)
1.43 
0.78 
1.01
Specific activity (counts/minute/milligram)
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The counting rate of a protein sample^ milled for 10 minutes 5 plotted against the weight of protein 
counted»
PLATE 3
The RIIC ball-mill used in the nreparation of dried protein eajaples for scintillation counting.
. :.M6;gyw ,j lS K ZAi5aÆ^^r T3âa? z ^  c — ii
PLATE 4
The agate capsule and agate balls used in the preparation of dried protein samples for scintillation counting.
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Figure 6. The specific activities of successive portions
of the same protein sample, treated in the agate ball-mill for increasing periods of time.
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In its final form^ the procedure adopted was to mill 
each protein sample for ten minutes, after which the protein 
powder was equally divided between two pre-weighed empty 
scintillator vials* The vials were re-weighed on an 
Oertling R20 analytical balance, and the weight of the 
protein sample determined by subtraction, within an error 
range of - 0*05 mg* 5 ml, ME 210 scintillator were 
measured into each vial, and after gassing with nitrogen, 
the vials were well-shaken and placed in a water-bath at 
90°C for 20 minutes. After cooling for 1 hour, the 
outsides of the vials were carefully cleaned with acetone, 
Plate 5 shows the appearance of the scintillator before 
and after gelling. A vial of normal scintillator fluid 
is shown for comparison. The protein samnles were counted 
using a Beckman LS 100 liquid scintillation counter, using 
the preset tritium channel, and a counting time of 20 
minutes,
The absolute efficiency of the method was determined 
in the following manner, A weighed sample of milled 
protein was placed in a hydrolysis tube and hydrolysed 
in 1,5 ml, 6N HCl for 24 hours at 100°C, The HCl was 
subsequently removed by repeated evaporation under vacuum. 
The residue of amino-acids was taken up in 25 ml, distilled 
water, and 0,2 ml, aliquots were counted in ME 250 (Nuclear 
Enterprises, Edinburgh) scintillation cocktail, with and
PLATE 5
The appearance of NE 210 scintillator showing, from left to right,NE 210 scintillator before gelation NE 210 after gelation NE 2X0 liquid scintillator10 mgs. protein suspended in a NE 210 scintillator gel.
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without the addition of an internal standard of an 
accurate dilution of lysine supplied by the 
Radioqhemical Centre, Amersham. The inclusion of the
internal standard allowed calculation of the efficiency 
with which the protein hydrolysate was being counted, 
and hence the calculâtiqn of the absolute specific 
activity of the original protein sample. A fresh sample 
of the same protein was now counted suspended in a gel 
as described above. Table 9 displays the results of 
these experiments.
Table 9
Scintill­ator Internal standard added(dpm)
Proteinadded(mg)
cpm dpmpro­tein
Effic- 1 iency i
NE 250 11,100 0 3,167 0 28.53
NE 250 11 ,100 10.00 3,696 —
m  250 0 10.00 1,214 5,430 22.36
NE 210 0 5.31 k&9 2,ââ9 16.96
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Conditions of incubation of diaphragm preparations
Krebs-Henseleit physiological buffer, pH 7,4 (Krebs 
and Henseleit, 1932) formed the basis of the incubation 
medium. The buffer was prepared as described in Section 1 
(page 45),
®H-(4,5)-lysine (Radiochemical Centre, Amersham) was 
added to the medium in sufficient amount to yield a final 
specific activity of 0.3 uCi/ml and the medium was divided 
into an appropriate number of aliquots. In the case of 
experiments involving the use of intact diaphragm 
preparations, 25 ml. of medium were added to each of a 
series of 50 ml. stoppered conical flasks, which were 
placed in a Gallenkamp metabolic shaker, and allowed to 
equilibrate to a temperature of 3?°C. Freshly excised 
muscles were dropped into the preheated medium, the 
flgsks were gassed out for 30 seconds with 95 : 5 (v/v)
O2 : CO2, firmly stoppered and shaken at 110 cycles/minute, 
usually for 2 hours. In the case of the cut diaphragm 
preparations incubation was carried out in 5 ml. of medium. 
At the end of the incubation period, the muscles were 
removed from the medium, excised from the rib-cage if 
necessary, and carefully blotted. The tissues were 
frozen in liquid nitrogen before storage at -40°C. The 
muscles were immersed in liquid nitrogen no more than 30 
seconds after being removed from the incubation medium.
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The uptake of lysine into total protein of di 
muscle from normal rats and rats bearing a Walker 256 
carcinoma
The animals were prepared as described on page 43 , 
and the intact diaphragms were excised. Diaphragms from 
control animals and timiour-bearing anhnals were incubated 
in Krebs-Henseleit medium containing ^H-(4,5)-lysine at a 
specific activity of 0.3 uCi/ml. The incubation was 
stopped after 2 hours. The total protein was extracted 
from the frozen muscles by the method described on page 49 , 
and the specific activities of the protein samples from the 
various muscles were determined.
The experiment was repeated using hemidiaphragms from 
the control and tumour-bearing animals. In this case the 
incubation medium was made 5 mM with respect to lysine, and 
the specific activity of the medium was raised to 3 uOi/%1.
Further experiments with hemidiaphragms were carried 
out where the incubation was supplemented with amino-acids 
in the amounts shown in Table 10 . These amino-acid 
concentrations are approximately double those found in the 
serum of normal rats (Scharff and Wool, 1964; Schimassek 
and Gerok, 1965; Clemens and Kcrnor,1970). The activity 
of the medium was 3 uCi/ml,
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Table 10
Amino-acid Concentration uM/100 ml.) ■ Amino-* a eld 'Conc'entrat ion (uM/100 ml.)
Arginine 44 alanine 80
asparagine 8 valine 40
aspartic acid 8 methionine 14
threonine 58 isoleucine 19
serine 5Ô leucine 34
glutamic acid 38 tyrosine 18
glycine 43 phenylalanine 16
histidine 18 lysine 96
proline 48 cysteine 88
glutamine 38 j tryptophan 14
The effect of incubation time upon the juptake of lysine 
into protein of hemidiaphragms from normal rats and rats 
bearing a Walker 256 carcinoma
The animals were prepared as described on page 
The hemidiaphragms were excised and incubated in medium 
containing lysine at a specific activity of 0.3 uCi/ml. 
Hemidiaphragms from control and tumour-bearing animals 
were removed after , 1-, 2- and 3-hour incubation periods. 
The muscles were frozen, and the sarcoplasmic and myofibrillar 
fractions were prepared, dried and counted.
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The experiment was repeated upon a further group of 
control and tumour-bearing rats, the incubation in this 
case being carried for two hours with all muscles.
The uptake of lysine into protein of hem id iaphragms 
from normal rats, incubated in serum from rats bearing 
a Walker 256 carcinoma
The animals were prepared as described on page 43 .
The rats were anaesthetised by an intraperitoneal injection 
of 0.4 lîîl. 6^ (w/v) sodium pentobarbitone (Abbott Laboratories 
Ltd., Kent) . Blood was removed from the heart using a 
finely-drawn pasteur pipette and pooled until 30-40 ml. 
had been collected from both normal and tumour-bearing rats 
(usually 4 or 5 animals). The blood was allowed to clot 
for 1 hour, and the serum collected by centrifugation at 
600g. for 30 minutes at 10°C. Sufficient lysine was 
added to the serum to give an activity of 0.6 uCi/ml. serum.
1 ml. of serum was placed in each of a series of 10 ml. 
stoppered conical flasks, and equilibrated to 37^0 in a 
Gallenkamp metabolic shaker. Further normal rats, which 
had been maintained under the same experimental conditions, 
were sacrificed, and the hemidiaphragms excised. One 
hemidiaphragm from each rat was placed in a conical flask 
containing serum from a normal rat, whilst the other was
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placed in a flask contaj.Waig serum from a tumour-bearing 
animal. The flasks wer© gassed for 50 seconds with a 
95:5 (v/v) 02:002 mixture, tightly stoppered and incubated 
for two hours at 37°0. At the end of the incubation 
period, the muscles were removed, blotted and weighed. 
Sarcoplasmic and myofibrillar proteins were extracted 
from the muscles and counted.
The experiment was repeated, the serum being supple­
mented with amino-acids as described on page 80, and the 
activity of the serum being increased to 3 uCi/ml. serum.
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The effect of insulin administered in vivo upon the uptake 
of lysine irr^^prpteins of hemid iaphragms from normal
rats and rats bearing a Walker 256 carcinoma
The animals were prepared as described on page 43 .
One hour before use, half of the rats were injected intra- 
peritoneally with 0.5 ml. of an insulin solution, of 
activity of 2 units/ml. (Boots Pure Drug Co., Ltd., Nottingham) 
The remainder of the animals were given an injection of 
0*9^ (w/v) NaCl. The hemid iaphragms were excised and 
incubated in medium containing lysine with a specific 
activity of 0.3 uCi/ml. for 2 hours. The protein fractions 
were prepared from the frozen muscles, dried and counted.
The effect of insulin administered in vitro upon the uptake 
of lysine into proteins of hemidiaphragms from normal
rats and rats bearing a Walker 256 carcinoma
The animals were prepared as described on page 43 •
The hemidiaphragms were excised and one hemidiaphragm from 
each animal was incubated in medium containing lysine at 
a specific activity of 0.3 uCi/ml., whilst the other hemi­
diaphragm was incubated in a similar medium with the addition 
of 0.1 units/ml. soluble insulin. The incubation period was 
2 hours, at the end of which time the muscles were frozen, 
and the fractions extracted and counted*
85
RESULTS and DISCUSSION
The uptake of lysine into total protein of diaphragm 
muscle from normal rats and rats bearing a Walker 256 
carcinoma
Table 11 shows that incorporation of lysine into the 
total intracellular protein of diaphragm muscle from tumour- 
bearing rats was significantly decreased.
Table 11 - The uptake of lysine into protein of intact 
diaphragms from normal and tumour-bearing rats
do unt s/m inut e/mg protein
Control 501 ± 11>:<
Tumour-bearing j 254 ^ 8 < 0.01
Results are expressed as the mean  ^standard error of 
5 rats.
** In this and following tables in this section, P refers to 
the statistical significance of the differences between 
the values obtained for the control and tumour-bearing 
rats.
The specific activity of the medium was 0.3 uCi/ml., 
and the incubation time was 2 hours.
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These results suggest that the tumour is exerting an 
inhibitory effect upon the incorporation of lysine into 
muscle protein. This decrease in uptake could be due to a 
decrease in the specific activity of lysine in the case of 
the preparation from the tumour-bearing animal due to 
dilution by unlabelled lysine arising from an increased 
catabolism of muscle protein. An attempt was therefore 
made to eliminate this possibility by increasing the lysine 
concentration of the medium to gmM, which is approximately 
10 times the amount found in normal rat serum. Table 12 
shows that there is still a significant decrease in 
incorporation under these conditions.
Table 12 - The effect of an increase in lysine content of the 
incubât ion medium upon the uptake of lysine into pro­
tein of hemidiaphragm from normal and tumour-bearing rats.
counts/min,/mg* protein P
Control
Tumour-bearing
972 ± 22*
555 ~ 26
—
<  0.01 !
Results are expressed as the mean - standard error of 5 
rats. The specific activity of the medium was 3 uCi/ml,, 
the lysine concentration 5mM, and the incubation time 
2 hours.
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It was possible that the decrease evident in the muscle 
from tumour-bearing animals (Table 11) could be due to a lack 
of specific amino-acids, other than lysine, essential for 
continuing protein synthesis. This was tested for by in­
cubating the muscles in a medium containing all of the amino- 
acids normally present in serum at twice the levels found in 
normal serum, and measuring the incorporation of lysine 
into the total intracellular protein. Table 13 shows that 
the protein in the muscle from the tumour-bearing animal 
took up significantly less labelled lysine than did the control 
muscles, under these conditions of incubation, demonstrating 
that the inhibition observed (Tables 11,12,13) was not due to 
any lack of amino-acids in the tumour-bearing animal.
Table 15 - The effect of an amino-acid mixture upon the
uptake of lysine into protein from diaphragm muscle 
from normal and tumour-be a ring rats.
C ount s/min./mg. pr ot e in P
Control 962 f 45*
Tumour-bearing 452 ± 14 <^ ' 0.01
>!< Results are expressed as the mean standard error of 5 rats 
The specific activity of the medium was 3.0 uCi/ml. and 
the incubation time was 2 hours.
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The effect of incubation time upon the uptake of ^H-lvsine 
into proteins of hemidiaphragms from normal rats and rats 
bearing a Walker 256 carcinoma
The results of this experiment are displayed graphically 
in Figures 8 and 9. Each point in these graphs represents 
the mean of the data from 5 rats. It can be seen that whereas 
the myofibrillar protein fraction exhibits the decrease in 
incorporation of isotope seen in the total protein experiments 
(Table 11), the sarcoplasmic proteins are virtually unaffected 
by the growth of the tumour. This experiment was designed to 
ascertain whether or nut the incorporation of labelled amino- 
acid into the protein fractions from healthy and diseased 
muscles was proportional to time. That this should be so 
is important to the interpretation of the data on the relative 
incorporations. The possibility existed, with such an in 
vitro systemÿ that when the diaphragm was removed from the 
tumour-bearing ahimal, and hence from the direct effects of 
the tumour, the effect of the tumour on the protein metabolism 
might have begun to revert to normal. The proportionality 
of the uptake of lysine with increasing time suggests that 
this is not the case, and that the system studied was truly 
exhibiting effects due solely to the growth of the tumour in 
the host animal.
On repetition of the experiment with a single incubation 
time of 2 hours, it was confirmed that the sarcoplasmic 
proteins of the muscle from the tumour-bearing animal exhibit
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a normal uptake, whilst the myofibrillar fraction shows a 
greatly depressed level of radioactivity (Table 14)-
Table I4 - Effect of the Walker 256 carcinoma on the uptake
of lysine into myofibrillar and sarcoplasmic proteins 
of rat diaphragm*
[ . nm- ,
Count s/minute/mg, prot e in sa rcopia smic myof ibrilia r p
Control 466 ^ 27* 509 i 15 —
Tumour-bearing 458 - 13 176 - 14 (0.01
Results are expressed as the mean - standard error of 6 rats. 
The specific activity of the medium was 0,3 uCi/ml, and the 
incubation period was 2 hours.
Clark and Goodlad (1971) showed that while incorporation 
of 14c-valine into both the myofibrillar and sarcoplasmic 
proteins of rat gastrocnemius muscle, essentially composed of 
white fibres, was significantly decreased in tumour-bearing 
animals, the proteins of the soleus muscle were relatively 
unaffected. The amino-acid incorporation into the medial 
head of the gastrocnemius muscle, which, like the soleus, 
is composed of red fibres, was however decreased. This 
suggestion that red muscle fibres vary in their ability to 
resist the action of the tumour is supported by the present
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results, ■which show that although the sarcoplasmic proteins 
are unaffected, amino-acid incorporation into the myofibrillar 
protein fraction is considerably decreased in diaphragm muscle 
from the tumour-bearing animal.
The differential effect upon the contractile and sarco­
plasmic protein must be attributed to some form of compartment- 
ation within the muscle cell, either physical or chemical.
The results could be explained in terms of separate amino-acid 
pools for the synthesis of myofibrillar and sarcoplasmic 
proteins. Velick (1956) interpreted his results on differen­
tial labelling of various muscle proteins to mean that H- 
meromyosin, actin and the glycolytic enzymes are synthesized 
from the same pool of protein precursors, while L-meromyosin 
is formed from a separate pool. Kipnis e;b al (I96I) 
investigated the kinetics of tracer amino-acid appearance 
in the intracellular pool and in cellular protein under 
steady state conditions in the intact rat diaphragm preparation. 
The concentration ratio of tracer amino-acid between the 
e^cbracellular and intracellular amino-acid pools approached 
equilibrium exponentially, whereas incorporation into cellular 
protein proceeded linearly from the earliest time studied.
These workers presented a theoretical formulation predicting 
the kinetics of amino-acid incorporation into cellular protein 
if the total intracellular amino-acid pool were an obligatory
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intermediate in protein synthesis. The marked deviation 
of experimental observations from those theoretically 
predicted was taken to indicate a functional heterogeneity 
of the intracellular amino-acid pool. Hider et al. (1969, 
I97I) claimed to have identified a discrete extracellular 
pool of amino-acids, with a different composition from the 
intracellular pool. Using high specific activities of 
tracer amino-acid, and a double-labelling technique, they 
detected a lag period before linear incorporation of ^^G- 
glycine into muscle protein, which they interpreted as show­
ing that the extracellular pool is the direct source of amino- 
acids for protein synthesis. Thus there is considerable 
evidence to support the view that compartmentation exists 
in muscle cells, and that it may be responsible for differing 
rates of synthesis in different proteins.
It has been shown above that the effect of the tumour in 
decreasing the uptake of amino-acids into muscle protein is 
not due to a deficiency of amino-acids, but the effect could 
be due to an inhibition of the transport of amino-acids from 
the medium to the pool responsible for protein synthesis. 
Furthermore, it cannot be assumed that alteration in the rate 
of incorporation of labelled amino-acid into protein is 
necessarily due to an alteration in the rate of synthesis of 
that protein. Simon et al. (1962) have stated that the
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relationship between the specific activity of a protein and 
the rate of protein synthesis is a direct one only provided 
that the specific activity of the tracer amino-acid in the 
free amino-acid pool responsible for protein synthesis is 
the same in all muscles under consideration, and that the 
level of tracer in the pool is also constant. If the tumour 
exerts any effect on amino-acid transport in the muscle, then 
these conditions would not be fulfilled. Thus the observed 
effect of the tumour could be due to an effect on the transport 
of the amino-acid.
Gan and Jeffay (196?) calculated that under steady state 
conditions, 30^ of the lysine incorporated into rat muscle 
protein was derived directly from protein catabolism. In 
the present case, therefore, if the depleting effect of the 
tumour was mediated by increasing the rate of protein catabolism 
in muscle, the net result would be dilution of the tracer 
amino-acid in the free amino-acid pool. This would lead to 
a decreased incorporation of the tracer into protein even 
although the absolute rate of protein synthesis may be 
unaltered.
Clark and Goodlad (1971) did show that the ratio of 
RNA/DNA in gastrocnemius muscle from tumour-bearing animals 
was decreased, and suggested that this might indicate that 
the action of the tumour was directed at protein synthesis. 
However, until more data has been obtained on the nature of
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the ainino-acid pools responsible for the provision of 
precursors for protein synthesis in muscle, and the effect 
of the tumour growth upon these pools has been elucidated, 
it will be impossible to define the site of action of the 
tumour upon the muscle.
The uptake of lysine into protein of hemidiaphragms from 
*Lrat8j incubated in serum from rats bearing a Walker 
256 carcinoma
Table 15 shows that the uptake of lysine into myo­
fibrillar but not into sarcoplasmic proteins by isolated 
hemid ia pnragms from normal rats is decreased when they are 
incubated in serum from a tumour-bearing rat compared to the 
activity they exhibit when incubated in serum from a normal 
rat.
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Table 15 - The uptake of lysine into protein of hemi­
dia phragms from normal rats, incubated in serum from 
normal or tumour-bearing rats,.
Control serum 
Tumour-bearing serum 
P
Count s/minute/mg. prote in
smic myofibrillar
.3 j; 7,2* 77.0 ± 5.2
•5 ^ 4,4 54.1 i 1.9
n.s. <0,01
Results are expressed as the mean i standard error of 6 rats 
The specific activity of the serum was 0.6 uCi/ml, and the 
incubation time was 2 hours.
Again there is a possibility that this effect is due to an 
amino-acid abnormality in the serum of the tumour-bearing 
animals. El Me hairy (1950) found an increase in oK,*-aminô- 
nitrogen in the blood of tumour-bearing mice ^ and Wu and 
Bauer (1960) using a semi-quantitative assay method, concluded 
that the free amino-acids in the plasma of rats bearing large 
tumours were increased at the expense of muscle proteins as 
the wasting process progressed during tumour growth.
A higher level of amino-acids in the serum of tumour- 
bearing anima].8 would serve to dilute the added isotope and 
consequently would result in a decreased incorporation of
95
tracer into the muscle protein. Equally, should there be 
a specific or non-specific deficiency of amino-acids in the 
serum, protein synthesis would be limited, leading to a 
decreased incorporation* However, although this could be 
a significant factor vivo, it would be unlikely that such 
a decrease would be evident in the present design of experiment, 
since the normal muscle would have sufficient amino-acids 
present to function normally, even with a deficiency in its 
incubation medium.
In an attempt to eliminate possible alterations in 
serum amino-acid levels due to the tumour as the causative 
effect of observed results, the serum from normal and tumour- 
bearing animals was ^flooded^ with an artificial mixture of 
the naturally occurring amino-acids, in sufficient amounts to 
raise the level of the amino-acids to at least three times 
the concentrations found in normal circulating rat serum.
By this means it was hoped that the effect of any disparity 
in the amino-nitrogen concentrations would be reduced* In 
fact, Table 16 shows that the decrease in incorporation is 
still very apparent, so that it would appear that amino-acid 
concentration is not the cause of this inhibition of 
incorporât ion.
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Table 16. - The effect of the addition of an amino-acid
mixture on the uptake of lysine by normal 
rat diaphragm muscle, incubated in serum from 
normal and tumour-bearing rats.
count s/minute/mg * protein
Control rat serum 2â9 - 12*
b serum 176 ± 15
P
< 0*01
Results are expressed as the mean f standard error 
of 5 rats*
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The effect of insulin upon the incorporation of lysine 
into proteins of diaphragm muscle from normal rats and rats 
bearing a Walker 256 carcinoma
Normal blood plasma or serum stimulates both the uptake 
of glucose by the isolated rat diaphragm (Green et al., 1952) 
and the incorporation of glycine into the protein of the 
diaphragm (Manchester and Young, 1959)# This enhancement is 
abolished by the addition of guinea-pig antiserum to ox insulin 
to the incubation medium (Manchester and Young, 1959)* This 
indicates that the enhancement noted on the addition of serum 
is due to the presence of a resting level of insulin in plasma 
and serum. Manchester and Young (1959) demonstrated that 
insulin was stimulatory to glucose uptake and protein synthesis 
upon addition to the incubation medium at levels as low as 
0.5 milliunits/ml. Goodlad and Mitchell (unpublished results) 
showed that the average level of insulin in the plasma of 
tumour-bearing rats, maintained under the same dietary 
conditions as those described on page 43 , was reduced to 
11,3 microunits/ml., as opposed to the control value of 16.5 
microunits/ml. It is possible therefore that the decreased 
incorporation observed in the muscles incubated in the serum 
of tumour-Gearing rats (Table 15) could be due to a 
deficiency of insulin in the serum.
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In an attempt to obtain further information on this 
point some experiments were carried out to study the effect 
of an injection of insulin on the jri vitro amino-acid 
incorporation by sarcoplasmic and contractile proteins of 
the diaphragm of tumour-bearing rats. Kurihara and Wool 
(196â) found that in Vitro incorporation of labelled amino- 
acids into both sarcoplasmio and myofibrillar protein fractions 
of hemidiaphragm of diabetic rats was reduced by 50*3% and 
65*7% respectively. If the diabetic rats were given insulin 
intraperitoneally 1 hour before-they were killed the to vitro 
incorporation of amino-^acid into both these fractions was 
restored to normal levels.
Tables 17 and 18 ShoW the effect of an injection of 
1 unit insulin on amino-acid uptake into the two muscle 
protein fractions of diaphragms of normal and tumour-bearing 
rats.
99
Table 17 - The effect of insulin administered to vivo 
upon the incorporation of lysine into sarco­
plasmic protein of diaphragm muscle from normal 
rats and tumour-bearing rats.
Insulin1addition
count s/minute/mg. protein 
control tumour-bearing
**
Pi
431‘i â * 4^9 - 22 <0.05
•f* 476 ± 32 543 i 22 n.s.
p,- n,S. n*s. i
* Results are expressed as the mean 1 standard error of 
5 rats.
** In this and following tables, refers to the
statistical significance of the difference between 
control and tumour-bearing animals, while refers 
to the statistical difference between insulin-treated 
muscles and non-insulin-treated muscles.
The specific activity of the medium was 0.3 uCi/ml. and 
the incubation time was 2 hours* 1u of insulin was 
injected intraperitoneally into the rats 1 hour before 
they were killed.
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Table 18 - The effect of insulin administered to vivo 
upon the incorporation of lysine into myo­
fibrillar protein from diaphragm muscle from 
normal rats and from tumour-bearing rats.
Insulin
addition
counts/minute/mg.protein 
control tumour-bearing
+
Po
430 i 12 =!■ 
621 i 32 < 0.01
154 16
247 - 30 
<  0.05
< 0.01 
< 0,01
* Results are expressed as the mean i standard error of 5 rats.
The data obtained for sarcoplasmic proteins and myo­
fibrillar proteins was statistically treated according to 
the analysis of variance method (Colquhoun, 1971)* The 
computer program written to accomplish this analysis is given 
in the Appendix. Table 19 shows the results of the analysis 
of variance. Comparison of the significance calculated by 
this method, and the significance calculated by Student^s 
t-test, (Tables 17,18), enabled the following conclusions 
to be drawn from the experiment.
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Table 1g - Analysis of variance of the vivo effect of 
insulin on the incorporation of ^H-l^^sine into 
diaphragm muscle protein fractions from normal 
and from tumour-bearing rats.
Source of variation
j w w  - T t n » » - » » w a ' m f c * 1 1 1 1 -
Degrees of freedom F-value p
Replicates 4 0.70 n. s.
Tumour-bearingcontrol 68.74 < 0.01
Insulin - saline 1 29.14 < 0,01
Muscle fraction 1 64.53 < 0.01
Interaction between tumour and musclé 1 fraction -I 131,90 < 0.01
1 Interaction between ! tumour and insulin 1 0,15 n.s.11 Interaction between 
:  insulin and muscle 1 fraction 1 8.39 < 0.05
1
3-factor interaction 1 0.37 1!  n.s,
iResidual 2Ô _ 1
f
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The tumour, as has alread^r been shown, has a greater 
effect upon the myofibrillar fraction than on the sarco­
plasmic fraction of the muscle. Insulin also exerted a 
significantly greater effect upon the myofibrillar fraction 
of the muscle protein. The effect of insulin was not 
significantly different in the tumour-bearing animal than 
in the normal animal.
With the dose of insulin used in the present work, 
although the hormone tended to increase incorporation into 
the myofibrillar fraction, the extent of this increase was 
far from being of sufficient magnitude to restore the 
incorporation in the normal animal. The effect of insulin 
on protein synthesis in tumour-bearing animals is not 
therefore as marked as it is in the diabetic animal.
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Upon testing bhe effect of insulin by in vitro 
administration, the data shown in Tables 20, 21, 2 2, 
were obtained.
Table 20 - The effect of insulin administered in vitro. . . . .  .   . . .       -  ■  —  ^  r m ir r i i i ii
upon the uptake of lysine into sarcoplasmic 
protein from diaphragm muscle of normal rats and 
tumour-bearing rats.
Insulin
addition
count8/minute/mg.prot e in 
control tumour-bearing
463 i 27 * 
479-1 8  
n.s.
492 i 18 
571 i 20 
< 0.02
1
n.s.
< 0,02
% Results are expressed as the mean i standard error of 
7 rats.
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Table 21 - The effect of insulin administered in vitro 
upon the uptake of lysine into myofibrillar 
proteins from diaphragm muscle of normal rats 
and tumour-be a ring rats.
Insulin 
addit ion
2
counts/minute/mg. protein 
control tumour-bearing
447 - 21*  
617 - 10 
< 0.01
175 i 16 
187 ± 18 
n.s.
Pi
< 0.01 
< 0.01
Results are expressed as the mean i standard error of 
7 rats.
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Table 22 - The analysis of variance of the effect of
insulin vitro on the incorporation of lysine 
into diaphragm muscle protein fractions from normal 
and tumour-bearing animals.
Source of variation Degrees of freedom F-value p
Replicates 6 1 ,30 n.s.
Tumour-bearing - control 1 143,46 < 0.01
Insulin - saline 1 20, ao < 0.01
Muscle fraction 1 147e57 < 0.01
Interaction between tumour - insulin 1 2,07 n.s.
Interaction between insulin - muscle fraction 1 2,21 n.s.
Interaction between tumour - muscle fraction 1 251;93 < 0.01
3-factor interaction 1 11.90 < 0.01
Residual 42 —
[ ________
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Examination of the data in Tables 20 , 21 and 22 
confirms that the effect of insulin is markedly reduced 
in the muscles from tumour-bearing animals. The tumour 
exerts its usual effect upon the myofibrillar fraction of 
the muscle protein, and the to vitro addition of insulin 
does not enhance the incorporation of label into this 
fraction in the tumour-bearing animal, as it does in the 
control. Throughout the experiments reported in this 
section, the sarcoplasmic fraction of tumour-^bearing 
muscle tended to show a slight, but not significant, 
increase in incorporation, compared with the control.
In vitro addition of insulin magnified this effect to the 
extent that a significant difference was noted (P<0,02) 
(Table 20 ),
In no case was the level of incorporation into the 
myofibrillar fraction of protein from diaphragm muscle from 
a tumour-bearing animal restored to its n.ormal level in 
the control animal by the action of insulin. This, together 
with the fact that the muscle from the tumour-bear tog animal 
retains to a small degree the ability to respond to the 
stimulating action of insulin, indicates that the depression 
of the level of incorporation of tracer amino-acid 
into protein from the muscle of tumour-bearing animals 
is not due exclusively to a deficiency either in insulin 
level or in the mechanism of action of insulin on the 
muscle.
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SECTION 3
The preparation, purification and bioassay 
of a t0X0hormone fraction from the Walker 
256 carcinoma.
The effect of toxohormone upon the uptake 
of lysine into proteins of diaphragms from 
normal rats.
INTRODUCTION
The concept of a toxin secreted by the tumour, producing 
the biochemical injuries characteristic of cancer-bearing 
hosts, has already been discussed (page 23), In the experi­
ments described in this section, a toxohormone fraction was 
prepared and purified, and its influence upon the uptake of 
a labelled amino-acid into rat-diaphragm muscle protein was 
investigated.
The observation that liver catalase activity is markedly 
reduced in cancer patients and in tumour-bearing animals is 
of long-standing (Blumenthal and Brahn, 1910; Rosenthal,
1912; Brahn, 1914, 1916), Various methods were tried in 
the attempt to isolate a hypothetical liver catalase reducing 
factor from cancerous tissues in a sufficiently concentrated 
state to be measured in a biological assay system,
A polysaccharide fraction was isolated from tumour tissue 
by extraction with dilute trichloracetic acid, and a lipid 
fraction was obtained by extraction with ether. Both of 
these extracts were highly toxic to animals into which they 
were injected, but they did not possess any liver catalase 
depressing activity (Nakahara and Fukuoka, 1961),
A fraction was obtained by extracting various human 
malignant tissues with hot water, followed by ethanol 
precipitation (Nakahara and Fukuoka, 194&) . This fraction
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proved to be active in the depression of mouse liver catalase 
upon intraperitoneal injection in doses of 100 mg, and more 
(Nakahara and Fukuoka, 1948, 1949, 1950), Toxohormone 
fractions isolated by this method were proteins, but contained 
nucleic acids, often amounting to as much as 30^ by weight. 
There are conflicting reports on the activity of the nucleic 
acid fraction; Nagagawa et al.. (1955) separated a crude 
toxohormone fraction into protein and nucleic acid components. 
The fractiohation was accomplished by treatment with hot 
trichloracetic acid, which removed the nucleic acids, leaving 
the protein component. The nucleic acid fraction was prepared 
by alcohol precipitation of the supernatant from the hot 
trichloracetic acid treatment. Nagagawa et ajL, (1955) 
claimed that of these two fractions, the nucleic acid was the 
more active in causing a depression of liver catalase activity. 
It would seem likely, however, that hot trichloracetic acid 
treatment would degrade the nucleic acids originally present, 
leaving these results open to some doubts An active toxo­
hormone fraction was isolated from human gastric carcinoma 
which showed a maximal absorption at 260 nm and contained no 
free amino-groups (Kuzin et aj,., 1955), although this fraction 
was not positively identified as nucleic acid.
On the other hand, Nakahara and Fukuoka (1949) found no 
activity in a nucleoprotein^ component of their toxohormone
preparation, Endo (1954) isolated nucleic acids from tumour 
tissue by the method of Clark and Schryver, and found 
them to be without toxohormone activity.
It now seems probable that toxohormone is a polypeptide, 
and the fact that nucleic acid seems to be closely adherent 
to many toxohormone preparations suggests that toxohormone 
may be a basic polypeptide. This view is substantiated by 
the findings that methanol-acetic acid and picric acid extracts 
of tumours containing polypeptide material were active in 
depressing liver catalase activity (Ono et 1955; Fujii 
et al,, 1960). These basic protein preparations were more 
active than any previously described, producing highly 
significant depression of liver catalase activity in doses 
of between 5 end 10 mg*
Various attempts have been made to further purify these 
crude fractions* Trojanowski et al. (1969) attempted to
purify material prepared according to Nakahara’s original 
method (Nakahara and Fukuoka, 1948), using ammonium sulphabe 
precipitation followed ly Sephadex gel filtration, and obtained 
five fractions, the most active of which depressed the level 
of mouse liver catalase in doses of 100 ug* This level of 
purification was not as good as that achieved earlier by Yunoki 
and Griffin (I96O, 196I) using cation-exchange chromatography, 
and Nixon and Zinman (I966) using anion-exchange chromatography
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on DEAE-cellulose, These workers obtained preparations
active at doses of 10 ug^ per mouse.
Toxohormone production appears to be a general property 
of cancer cells. There has been no report of a malignant 
tumour, whether spontaneous, transplanted or chemically 
induced, which did not yield active toxohormone, Greenfield 
and Meister (1951) isolated an active toxohormone fraction 
from the Walker carcinosarcoma, which, upon injection in 
doses of 50 mg,, réduced the level of mouse liver catalase.
The methods used in the present work for the isolation of 
toxohormone were based upon those of Yunoki and Griffin (i960). 
Like the method of Ono et al- (1955), this procedure was 
designed to extract a basic polypeptide fraction from the 
tumour tissue. The technique was originally designed for 
the isolation of adrenocortlcotrophic hormone from pituitary 
tissue by Payne et al. (1950), This particular method was 
chosen because when it had been applied to human malignant 
tissue, the toxohormone isolated was very active (Yunoki and 
Griffin, I96O), The toxohormone fraction isolated and 
purified by this technique was shown tc contain 20^  lipid 
(Yunoki and Griffin, 196I), but an absolute requirement of 
lipid for toxohormone activity was not demonstrated,
A great deal of the research into toxohormone has been 
devoted to establishing that it is a product of living tumour
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cells, and that it is not related either to the products of 
tissue necrosis or to bacterial contamination of the tumour. 
Nakahara and Fukuoka (1949) showed that necrotic and non- 
ne erotic portions of cancerous tissue do not differ signifi­
cantly with respect to the yield or potency of toxohormone.
The possible involvement of bacteria in causing toxohormone 
production was suggested bv Kampschmidt et al. (1963) who 
claimed that contaminating Salmonella typhiimurlum was the 
most potent source of toxohormone in tumour tissue*
Nakahara and Fukuoka (1949) divided a sample of tumour tissue 
into two portions without aseptic precautions, isolated the 
toxohormone fraction from one portion immediately, and from 
the other portion after incubation overnight at 37°G * Similar 
amounts of toxohormone of approximately the same activity 
were obtained in both cases, and Nakahara and Fukuoka inter­
preted these results to mean that not only is toxohormone un­
related to the tissue decomposition, but also that the amount 
of micro-organisms which may be contained in tumour tissue 
cannot be of material importance.
Further evidence against micro-organisms present in the 
tumour being the main source of toxohormone was presented by 
Matsuoko et al (1964) and Nakahara et al. (I966). The 
former group of workers found that the addition of 0,1^ of 
Salmonella typhimmurium to 55 g# of sterile sarcoma tissue had
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little effect on the amount of potency of toxohormone 
isolated from the tumour* The amount of bacteria they 
added was in fact approximately 100 times that obtained 
from 1 ml of pure culture under conditions of maximal 
growth. The latter group showed that bacteria-free 
tumours transplanted and maintained in germ-free mice 
were as rich a source of toxohormone as tumours obtained 
from conventional mice* It is also probable that viruses 
have no ability to produce or stimulate the production of 
toxohormone in the neoplastic cell (Ohashi, 1961),
Although these experiments would appear to preclude the 
possibility that toxohormone production in tumours is entirely 
due to bacterial activity, there is evidence that toxohormone- 
like materials may be isolated from bacteria or bacterial 
cultures. Thus Matsuoko et ajL. ( 1964) found that 1g of 
S, typhimurium yielded 33mg of such a factor, and 
Kampschmidt et ( 1963) isolated and purified lipo- 
polysaccharide endotoxins from several bacteria, which were 
shown to cause marked depression of liver catalase activity 
when injected into rats at a level of lOOug per 200g body 
weight, A great deal of the confusion with regard to the 
role of bacterial contamination in being a prime factor in 
the effect of the tumour on its host is undoubtedly due to 
the concentration of workers on the phenomenon of liver 
catalase depression. The Japanese workers have defined
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toxohormone as a substance present in high concentrations in 
tumours, which possesses this property (Nakahara and Fukuoka, 
1948). The relevance of liver catalase depression to the 
cachectic effect of the tumour remains obscure. Some 
tumours cause very little depression of the activity of the 
enzyme (Kampschmidt et a2., 1963) and some tumours contain 
a high level of catalase activity though they are rich 
sources of toxohormone (Rechcigl and Sidransky, 1962). In 
contrast to liver catalase depression, other systemic 
effects of the tumour on its host appear to be independent 
of whether the tumour is contaminated by bacteria or not.
Thus Kampschmidt and Upchurch (1963) found that liver, 
spleen and adrenal weight are increased and thymus weight 
decreased in rats bearing either a becteria-free Walker 
tumour or one contaminated by Salmonella typhimurium.
Bacterial endotoxins have, however, been shown to have the 
property of lowering plasma iron levels (Kampschmidt and 
Schultz, 1961 ; Kampschmidt and Upchurch, 1962),
The methods available for the assay of liver catalase 
activity are all based on the method of von Euler and 
Josephson (1927), in which the enzyme reaction is carried 
out at 0°C in a buffer containing hydrogen peroxide. The 
extent of the reaction is then estimated by measurement of 
the remaining hydrogen peroxide, either spectrophotometrically
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(Chantranne, 1955), titrimetrically using KMnO^, or by 
measurement of the evolved oxygen (Greenstein, 1942),
Although the measurement of the depression of liver 
catalase activity has been the most widely used method for 
the bioassay of toxohormone (Nakahara and Fukuoka, I96I ; 
Nakahara, 1967), several of the other reported effects of 
toxohormone, listed in Table 23, have been employed. In 
particular, the depression of the level of plasma-bound 
iron has been found to give a rapid and sensitive measure­
ment of the activity of toxohormone fractions (Kampschmidt 
et al,, 1959). These workers showed that the plasma bound 
iron level was 250-500 times as sensitive to toxohormone as 
liver catalase and that the maximum effect was noted after 
10 hours, as opposed to 24 hours for the liver catalase 
effect. The draw-back to the use of this technique on a 
routine basis was that the methods available for the 
estimation of plasma iron were very tedious and potentially 
more inaccurate than those described for liver catalase.
Iron is carried in the. plasma linked to the protein 
transferrin, and dissociation of the iron-protein linkage 
is a necessary first step in any method for the determination 
of plasma iron. Most of the early methods accomplished this 
by means of dilute acid hydrolysis and precipitation of the 
plasma proteins (Kitzes et al,> 1944? Kaldor, 1953; Schade 
et al,. 1954; Trinder, %956), Barkan and Walker (1940)
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accomplished the dissociation by reducing the pH of the 
plasma to about 6 with a concentrated buffer, so that the 
plasma proteins stayed in solution. Schade et al. (1949) 
showed that all the iron is not released from the protein 
complex at this pH, and it is unlikely that all the iron 
could be released by this method without causing precipitation 
of the serum proteins.
Sanford (1963) introduced a method for the estimation 
of plasma iron based on previous work by Webster (i960), 
who used a detergent in the measurement of iron-dextran in 
blood after intravenous injection. Sanford (1963) found 
that this detergent (Teepol 610) effectively liberated iron 
from its plasma-protein complex. This release was achieved 
by the combined action of Teepol and ascorbic acid. Teepol 
alone slowly liberated the iron, and the addition of the 
ascorbic acid, with consequent lowering of the pH value, 
accelerated liberation. The iron is completely released 
at pH 6.3. Teepol also acts as an anionic detergent, and 
prevents precipitation of the plasma proteins . The released iron 
is complexed with bathophenanthroline (Trinder, 1956) after 
reduction to the ferrous state by ascorbic acid, and estimated 
colorimetrically.
One of the main disadvantages of the acid precipitation 
method is that haemoglobin iron is also released to some extent 
by the action of the acid. Schade et al. (1954) and Ramsay
117
(1953) stated that the iron released from luM of haemoglobin- 
iron complex in 100 ml. serum interferes significantly with 
the estimation of plasma iron. Teepol does not remove iron 
from its haem complex, and Sanford (1963) demonstrated that 
up to 4 #1/100 ml. haemoglobin-iron complex has no effect 
upon the measured value of plasma-bound iron, although the 
value of the internal blank is altered (Beale et al., 1961).
Nakahara (196?) points out that doubt still exists as 
to the identity of the substance(s) responsible for the effect 
upon plasma bound iron and toxohormone in the strict sense, 
which brings about the decrease of liver catalase activity.
In the present work, liver catalase depression was followed 
in the preliminary experiments, but in later studies the 
ability of the toxohormone fractions to depress the level 
of plasma-bound iron was assayed.
Due to the lack of knowledge of the degree of purification 
of toxohormone fractions which have been isolated, there are 
few reports of physical characterisation of toxohormone.
Several workers have performed amino-acid analysis on their 
partially purified preparations (Ono et al., 1957; Yunoki 
and Griffin, 1961), Molecular weight estimations have been 
restricted to those based upon end-terminal analysis (Yunoki 
and Griffin, 1961) or Sephadex gel filtration (Trojanowski, 
1969). Amino-acid analysis and an ultracentrifugal molecular 
weight determination were therefore perforn od on the })ighly
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purified toxohormone preparation obtained in the present 
work.
In view of the striking cachectic effect of the growth 
of the Walker 256 carcinoma in rats, emphasized in the 
previous sections, and the depression in the uptake of 
radioactive amino-acids by diaphragm muscle protein from 
tumour-bearing rats, reported in Section 2, the effect of 
toxohormone, administered to vivo and to vitro, upon the 
uptake of a labelled amino-acid into diaphragm muscle 
protein was investigated.
A possible influence of a toxohormone preparation upon 
protein synthetic processes has been reported only once, by 
Obara and Ono (196$). These workers prepared toxohormone 
using a modification of Ono^s method for the basic protein 
toxohormone fraction (Ono et al., 1955), and further purified 
the preparation using CM-cellulose., Their frefined^ toxo­
hormone was effective in reducing the uptake of 14G-leucine 
into the proteins of rat lens and cornea by a factor of 10, 
in an to vitro incubation system. The doses employed were 
40 - 200 ug/ml medium, although there appeared to be little 
increased effect with increased dose, after the initial 
reduction due to the addition of 40 ug/ml toxohormone.
For the to vivo experiment in the present work, the dose 
was selected on the basis of the dose required to produce an
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effective depression in the level of plasma iron in mice, 
the amount being increased to allow for the greater weight 
of the rat. The time lag between the injection and the 
sacrifice of the animals was chosen on the basis of the 
reported effects of toxohormone listed in Table 23 #
Those effects such as thymus involution and adrenal hyper­
trophy which might be expected to involve alterations in 
protein metabolism do not become significant until at least 
24 hours has elapsed since the first injection. The 
experiment was therefore designed so that one group of 
animals were killed 3 hours after their second injection 
of toxohormone, whilst a second group were killed 2? hours 
after their second injection. In this way, it was hoped 
that any short term transitory effect of the toxohormone 
would be detected, as would a longer term cumulative effect, 
In the to vitro experiment, the toxohormone was added 
to the incubation medium so as to render the final concen­
tration of toxohormone in the medium in excess of the 
concentration which could be expected in rat plasma during 
the to vivo experiment, Obara and Ono (1965) claimed that 
a toxohormone concentration of 40 ug/ml medium was sufficient 
to cause a significant effect on the synthesis of corneal 
and lens protein, whilst the injection of I6OO ug over a 
period of 4 days was necessary to cause the depression of
Jl20
Table 25 ~ Reported effects of toxohormone following 
in vivo administration
Effect Î ü î i e '  after administrât ion (hrs,) Source
Liver weight increased 24 Kampschmidt gb al.(1959)
Thymus weight decreased 48 ÎÎ
Spleen weight increased 24 Î?
Adrenals weight increased 10 Ï?
Liver catalase activity decreased 24 ÎÎ
Kidney catalase activity decreased 24 Î!
Haemoglobin level decreased 72 ÎÎ
Plasma-bound iron level decreased 10 ÎÎ
Unesterified iron binding capacity increased 10
 ^Liver protoporphy­rin level increased 24 Nakahara(I96O)
Liver ferritin level decreased 20 ÎÎ
NAD s^mthesis decreased 24 SÎ
Liver ascorbic acid level decreased 24 Hoshizima
( 1 9 5 8 )
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mouse liver catalase. Although this indicates that 
toxohormone is more potent to vitro than to vivo, the 
dose administered in the present experiment was greater 
than that required to produce a significant depression 
in mouse plasma iron content.
122
EXPERIMENTAL
Preparation of toxohormone
The methods used for the preparation and purification 
of toxohormone were based upon those of Yunoki and Griffin 
(1960).
Préparât ion of a crude toxohormone fraction
Tumours were excised from rats bearing large Walker 
256 carcinomas and stored at -40®G. 500 g of tumour tissue.,
which represented the accumulation from twelve to fifteen 
rats, were normally processed at one time. The frozen 
tumours were weighed and homogenised with approximately 
3 volumes of acetone in an MSE Ato-Mlx blender for 10 
minutes, A further 2 volumes of acetone were added with 
stirring, and the homogenate allowed to stand for 12 hours 
at 4°G, The homogenate was filtered and the acetone 
powder washed with a further volûme of acetone. The 
powder was dried overnight under vacuum, 90 g of acetone 
powder were generally obtained from 500 g of tumour.
Two volumes of acetone were added to the acetone-dried 
powder and sixteen volumes of glacial acetic acid were added 
with stirring. The solution was heated to 70°G over the 
course of 30-60 minutes with constant stirring, and allowed 
to cool. The insoluble residue was removed by centrifugation
and traces of supernatant collected by washing the residue 
with glacial acetic acid. To the clear supernatant one 
two-hundredth volume of 5M NaCl and one half-volume of 
acetone were added, and, after vigorous stirring, the 
mixture was allowed to stand for 12 hours at The
precipitate was removed by centrifugation, and ah equal 
volume of ether was added to the clear supernatant, A 
large precipitate formed quickly and after two hours the 
mixture was centrifuged. The residue was thoroughly washed 
with acetone to remove acetic acid, dried under vacuum, and 
stored at -40°C, This fraction was designated crude toxo­
hormone; 6g were generally obtained from 90g acetone-dried 
powder.
Purification of toxohormone
(i) Ammonium sulphate fractionation
1g of crude toxohormone was dissolved in distilled water, 
and the ammonium sulphate concentration of the solution raised 
by drop-wise addition of 3,9M {Wi^)2^0^ at 0°C, Precipitates 
were collected by centrifugation at 20,000g for 10 minutes, at 
ammonium sulphate concentrations of 0,39M, 0*78M, 1.17M, 1,56M, 
1,95M, 2,34M and 2.73M. The fractions were redissolved in 
distilled water, and residual ammonium sulphate removed by ion- 
exchange chromatography (Hire et al, 1953; Moore £t al,, 
1958), A short column (3,0 x 0,0 cm) of Amber lit e IR-120
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(400 mesh) (Rohm and Haas, LtdJ was washed with 500 ml 
3N HCl, followed by distilled water until the pH of the 
eluate dropped to 5# The solution to be desalted was 
loaded, and the column was washed with distilled water 
until the eluate was neutral, and no precipitation was 
produced by the addition of a single drop of a saturated 
solution of barium hydroxide. The toxohormone fraction 
was eluted with 5N NHj^ OH, The contaminating ammonia was 
evaporated under vacuum, and the solution lyophilised*
(ii) Cation-exchange chromatography
Amberlite CR-50 (200 mesh) (Rohm and Haas, Ltd,) was 
cycled once through the sodium form before use. To 500g 
of the resin suspended in 2 litres of water, 240g NaOH were 
added over a period of 1 hour. The pH of the suspension 
increased to about 11, Stirring was continued until the 
evolution of heat subsided, and the sodium salt of the resin 
was washed by décantation with five 2 litre portions of 
water. The resin was further washed with water on a filter 
until the pH was reduced to 10, The resin was converted to 
the acid form by passing 10 litres of 3N HCl through the 
filter over a 4-hour period, and it was finally washed with 
6 litres of water. The acid form of the resin was stirred 
with 2 litres of 0,1M glycine-NaOH buffer, pH 9.00, The 
pH of the suspens ion was adjusted to pH 9 #00 by titration
W T
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with 4CK (w/v) NaOH. The buffer was removed by décantation 
and the process repeated until the pH of the resin suspension 
remained constant over two successive buffer changes,
A 2,5 X 40 cm column was packed with resin and washed 
with buffer at pH 9*00 until the pH of the effluent became 
equal to the pH of the buffer, 2g crude toxohormone was 
stirred with 200ml 0.1M glycine-NaOH buffer pH 9*00, for 
2 hours at loom temperature. Approximately 300mg remained 
insoluble and this was removed by filtration,, dried and 
weighed. The clear filtrate was applied to the column, 
and the column developed with 0,1M glycine buffer, pH 9#00, 
at a flow-rate of 300 ml/hour. The eluate was monitored at 
202nm with an LKB Uvicord MK II, Once the first fraction 
had been completely removed from the column, the pH of the 
eluant was gradually increased by the addition of 0,1M 
glycine buffer pH 11,00, using a 500 ml mixing chamber.
The fractions thus eluted from the cation-exchange 
resin were lyophilised and redissolved in the minimum 
volume of distilled water. Glycine and NaOH were removed 
by passing the solutions through a 1 ,5 90 cm column of
G-15 Sephadex (Pharmacia Ltd,, Uppsala), eluting with 
distilled water at a flow-rate of 30ml/hour,
The concentration of the toxohormone fractions eluted 
from the Sephadex column was determined by the method of 
Itzhaki and Gill (1964)*
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The micro-biuret method developed by Itzhak! and Gill 
(1964) is based upon the measurement of the ultraviolet 
absorption of the complex formed between protein and copper 
in strongly alkaline copper sulphate solutions.
The colour reagent consists of (w/v) CuSO.
in 5(% (w/v) NaOH* 1 ml^ of this reagent was added to 2 ml 
of the protein solution, and the colour allowed to develop 
for 5 minutes at room temperature before measuring the 
extinction at 310 nm*
A standard solution of bovine serum albumin was prepared, 
and the protein concentration of this solution determined 
by the microkjeldahl nitrogen method of Ma and Zuazaga (1942). 
This solution was subsequently used for the preparation of 
standard curves « A standard curve is shown in Figure 10 ,
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FiAui^ 10, Standard curve for the estimation of protein by the
micro*.biur<^‘t method of Itzhak! and Gill (I9 6 4 )# Bovine serum albumin v/as used to prepare the standard protein 
solution»
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The liver catalase depressing ability of toxohormone
The method used for the measurement of the depression of 
liver catalase activity was a modification of the method 
described by Adams (1950).
Four mice were injected int ra per it oneally with 1 ml of a 
solution of the toxohorraone fraction in water. A further four 
mice were injected with distilled water and served as controls ^ 
24 hours later the mice were sacrificed by stunning followed by 
exsanguination, and the liver rapidly removed. After weighing, 
the liver was immediately homogenised in 20 ml ice-cold water 
using an M.S.E. overhead homogeniser fitted with an ice-cold 
jacket. The volume of the homogenate was adjusted with ice- 
cold water so that the final concentration was 2 mg original 
wet weight of liver/ml homogenate.
1 ml of the diluted homogenate was pipetted into 50 ml 
ice-cold 0,01N hydrogen peroxide solution (in M/150 phosphate 
buffer pH 6.â) , A 5 ml sample was removed from the mixture 
after 2 minutes and dropped into 5 ml 2N sulphuric acid to 
stop the reaction. 10 ml 10^ (w/v) potassium iodide were 
added along with 1 drop 1^ (w/v) ammonium molybdate solution, 
and the iodine liberated from the iodide by any peroxide not 
decomposed under catalase action was titrated with 0.005N 
sodium thiosulphate solution, starch being added near the 
end-point tc act as indicator.
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A reaction constant was now calculated by application 
of the equation:
K « log ( a - x)
where a « initial substrate concentration 
a-x  ^final substrate concentration
The value of K obtained serves to provide a comparison 
between the catalase activity of two liver samples which 
have been diluted to the same concentration and incubated 
with substrate under identical conditions, provided that 
liver catalase activity is not affected by dilution of the 
homogenate. This possibility was tested by successively 
diluting a liver homogenate and estimating the amount of 
substrate used under the incubation conditions described 
above. The estimation at each homogenate dilution was 
performed in quadruplicate. The resulting reciprocal 
plot of enzyme concentration and volume of hydrogen peroxide 
destroyed is shown in Figure 11 , and the straight line
obtained shows that the K values calculated as described 
above can be compared with confidence.
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Figure 11» Reciprocal ÿlot of liver catalase enzyme concentration 
versus substrate destroyed.
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The plasma iron depressing ability of tQXohormone
The activity of a toxohormone fraction was assayed by 
its ability to depress the level of plasma-bound iron in 
mouse blood. Plasma-bound iron was estimated by a 
modification of the method described by Sanford (1965)^
Six mice were injected intraperitoneally with 1 ml of 
a solution of the toxohormone fraction in water, A further 
six mice were injected vrith distilled water, and served as 
controls. All injections were carried out between 2100 
and 2200 hours to minimise the influence of diurnal variation. 
Twelve hours later., the mice were anaesthetised by an int râ­
per it onea 1 injection of 0,15 ml 6^ (w/v) sodium pento­
barbitone , and blood removed from the heart using, a finely- 
drawn heparinised Pasteur pipette* Plasma was collected by 
centrifugation at 600g for 50 minutes.
Iron-free Teepol 610 reagent was prepared by adding an 
equal volume of water to Teepol 610 detergent (Shell Chemical 
Co.), The dilute detergent was passed through a 5,0 x 60 cm 
column of Zeo-Karb 225 (Permutit Co. Ltd,) in the sodium form. 
The Teepol reagent could be stored for several months at room 
temperature. Immediately before use, ascorbic acid was added 
to the detergent to make a final concentration of 0*75^ (w/v) 
ascorbic acid, 0,4 ml of the acidified Teepol solution was 
added to 0,1 ml mouse plasma and the extinction, measured
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at 546 nm, 0,1 ml of a 0,14^  (w/v) 4,7 diphenyl 
1,10 - phenanthroline disulphonate (bathophenanthroline) 
solution (British Drug Houses, Ltd,) was added, mixed well, 
and the extinction, measured, again at 546 nm. The 
extinction, of a mixture of 0^ 1 ml water, 0,1 ml 
bathophenanthroline and 0,4 ml Teepol reagent provided a 
reagent blank# The extinction due to the colour complex 
formed between ferrous iron and bathophenanthroline was 
calculated according to the formula:
E^ - E^ - (Ep X 0.835)
Calibration curves were prepared using a standardised FeCl2 
solution, and such a curve is shown in Figure 12 ,
The chemical structure of the complex formed by Fe^^ and 
bathophenanthroline is shown in Figure 13#
(b)
Fij;^ re 13.Xa; The chemical formulation of the points of chelation of the 
bathophenanthroline molecule and the ferrous ion,
(b) The spatial configuration of the bathophenanthroline
iron complex. The arrows refer to the electron-charing by two nitrogen atoms fran each bathophenanthx-oline 
molecule »
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Physical properties and chemical composition of the 
purified toxohormone fraction
Amino-acid analysis
Approximately 60 ug purified toxohormone was hydrolysed 
for 24 hours with 10 ml 6N HCl at 100^0^ Hydrochloric acid 
was removed from the hydrolysate by successive evaporation 
under vacuum. The residue of amino-acids were taken up in 
0,5 ml distil.led water, and analysed on a Locarte amino-acid 
analyser.
Presence of E M  and D M
The toxohormone preparation was tested for the presence 
of rib ose by the orcinol method (Bial et al., 1902; Schneider, 
1957) and for the presence of deoxyribose by the Ceriotti
method (Ceriotti, 1952, 1955) «
Ab.sorption spectrum
The ultraviolet absorption properties of the toxohormone 
dissolved in distilled water were monitored on a Unicam 
SP 800 double beam spectrophotometer.
Ultracentrifugal analysis
Ulthacentrifugal analysis was carried out in a Spinco 
Model E analytical ultracentrifuge. The meniscus depletion
equilibrium method of Yphantis (1964) was used.
••
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900 ug of purified toxohormone were dissolved in 1 ml 
70 (w/v) KCl, and the solution and solute placed in a 12mm 
capillary type synthetic boundary double sector cell, with 
sapphire end windows. Rotor speed was 44,770 rpm, and the 
depletion of the meniscus was monitored using the Rayleigh 
interference optical system.
The slope of the plot of log^g fringe displacement 
versus the square of the distance from the centre of the 
rotor was calculated by linear regression. O  was assumed 
to be 0*725 and to be 1*011. The weight average molecular 
weight was calculated by application of the equation:
2,303
]VU «  2RT X  --- — -- g X  slope^ (1
Where partial specific volume
P'S density
angular velocity of the rotor
This equation 1b due to Van Holde and Baldwin (1958) .
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The effect of toxohormone administered in vivo upon therzUptake of H-lysine into proteins of hemidiaphragms from 
normal rats and rats bearing a Walker 256 carcinoma
Twelve normal rats were maintained under experimental 
conditions as described on page 45 . Eight of these 
animals were injected int r a per it one a lly with 150 ug of toxo­
hormone purified by ion-exchange chromatography as described 
on page 123. The remaining four animals were given 
injections of distilled water. After 24 hours these 
injections were repeated. 5 hours later, four of the 
toxohormone-treated animals and two of the control animals 
were killed. The hemid iaphragms were excised and incubated 
in medium containing lysine with a specific activity of 
0,3 uCi/mlp for 2 hours, (as described on page 79). 51
hours after the initial injections, the remaining animals 
were killed and the hemidiaphragms similarly incubated.
The total protein fraction was prepared from the frozen 
muscles, dried and counted, as described pa'eviously (page49 ).
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The effect of toxohormone administered in vitro upon the 
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normal rats and from rats bearing a Walker 256 carcinoma
Normal male rats were maintained under the experimental 
conditions as described on page 43- The animals were 
sacrificed and the hem id iaphragms excised. One hemid ia phragm 
from each animal was incubated in medium containing lysine 
at a specific activity of 0*5 uCi/ml, (page 79 ), whilst the 
other hemidiaphragm was incubated in a similar medium with 
the addition of 30 ug/ml toxohormone. The incubation period 
was 2 hours. At the end of the incubation the muscles were 
frozen, and the total protein fractions were extracted and 
counted (page 49 ) .
RESULTS and DISCUSSION
Preparation of toxohormone
Crude toxohormone (TH) , prepared as described on page ii9, 
was assayed for its ability to depress the activity of liver 
catalase in mice* The results are shown in Table 24,
Table 24, - The depression of mouse liver catalase activity 
by a crude toxohormone fraction (TH)
Dose of TH/mouse
0 
100 
50 
25 
10
K X 10®
426 i 12- 
1 7 5 - 9  
2Ô6 i 17
331 ± 13 
402 ± 6
Percentage decrease in catalase activity
59.5
52.9
22.2
4.5
P=
< 0,01 
< 0.01 < 0.01
n.s
^ Results are expressed as mean - standard error of 4 mice 
In this table, and subsequent tables describing the bio­
assay of toxohormone, P represents the statistical 
significance of the percentage depression of the parameter 
under examination.
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A significant effect is maintained with doses down to 
25 mg (Table 24) , but a dose of 10 mg produced no significant 
depression in the liver catalase activity, Yunoki and 
Griffin (196I) claimed that their toxohormone sample was 
active in doses as low as 10 mg - although the percentage 
decrease which they obtained with this dose was only 2?^*
The depression produced by a 20 mg dose of their preparation 
was 58.5^ 0, so that their preparation appeared to be consider­
ably purer than that obtained in the present work by the 
same method.
Nevertheless, the fact that the material prepared from 
the Walker 256 carcinoma did produce a depression in activity 
of liver catalase qualifies the extract as toxohormone, as 
defined by Nakahara and Fukuoka (1948)*
The crude toxohormone fraction was next assayed for 
its ability to depress the plasma-bound iron level in mice, 
and the results of these assays are displayed in Table 25 *
137
Table 25 The depression of the level of plasma-bound 
iron in mice by a crude toxohormone fraction 
(TH) .
Dose of TH/mouse
i m L  __
Plasma iron level ( ug/100ml )
0 184 - 15*
10 100 i 6
5i 140 - 12
Percentage depression of plasma iron level
45 #4 
25.9
< 0.01 
<0,05
% Results are expressed as the mean - standard error of 6 mice,
With the plasma iron bioassay a considerable depression 
is produced by a dose of 10 mg crude toxohormone, and a 
significant effect can be detected from a dose of 5 mg.
These findings bear out the results of Kampschmidt et al.
( 1959) ) although the depression in the level of plasma iron 
produced in this instance was not nearly so precipitous as 
that reported by Kampschmidt, who claimed that injection of 
100 mg of a crude toxohormone preparation resulted in a 9<% 
depression of the level of plasma iron. It is likely that 
the greater effect obtained by Kampschmidt was not due 
entirely to the larger dose used, for the depression which 
he reported seemed to many workers out of proportion to
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what might be expected from the relatively mild degree of 
plasma iron depression in cancer-bearing patients and 
tumour-bearing animals (Nakahara, 196?), and bacterial 
contamination of Kampschmidt-^s toxohormone preparation 
was suspected. The subsequent work of Ono et aJL. (1960) 
and Nixon and Zinman (1966) showed, however, that a 
decrease of plasma iron does take place after the injection 
of toxohormone prepared from sterile tumours, although 
the depression is not as dramatic as first claimed by 
Kampschmidt *
The results obtained in the bioassay of the crude 
toxohormone preparation confirm that the plasma iron 
bioassay is more sensitive than the liver catalase assay 
(Tables 24 and 25).
A ftoxohormone ? fraction was extracted from foetal 
and placental tissue obtained from 20 day pregnant rats, 
in exactly the manner described for tumour tissue (pageIZl) 
The crude fraction thus obtained was subjected to bioassay, 
and the results are shown in Table 26. Bovine serum 
albumin was also assayed for toxohormone activity.
These tests were performed as a check that the 
depression of the level of plasma iron was in fact due 
uniquely to a tumour product. Foetal and placental tissue 
was chosen because like the tumour it is composed of
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rapidly dividing relatively undifferentiated cells. The 
fact that no alterations in plasma iron levels were induced 
by either foetal and placental tissue extract or bovine 
serum albumin supports the view that the toxohormone fraction 
studied was a tumour cell product.
Table ~ The depression of the level of plasma iron
in mice by an extract prepared according to Yunoki 
and Griffin (1960), from foetal and placental tissue, 
and by bovine serum albumin.
!----  —Injected material (dose in mg) Plasma iron level (ug/100mg)
' Përcërïëagè depression of plasma iron level p
distilled water 204 - 15- — -
foetaland placental extract (11.3) 213 i 9 —
bovine serumalbumin (10.0) 193 i 12 5.3 n.s.
^ Results are expressed as the mean à standard error of 
6 mice.
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Ammonium sulphate fractionation of crude toxohormone
Several ammonium sulphate fractions were prepared and 
desalted as described on page 122, and each fraction was 
subjected to bioassay for toxohormone activity. The 
results of these assays are shown in Table 27, and indicate 
that considerable purification of the crude toxohormone 
can be achieved by use of ammonium sulphate fractional 
pre c ipit at ion,
Trojanowski (1969) employed ammonium sulphate 
precipitation coupled with Sephadex chromatography, and 
obtained five fractions, the most active of which signifi­
cantly lowered the level of liver catalase activity in 
doses of 100 ug. Table 27 shows that the most active 
fraction obtained in the present work was that precipitated 
by 2,73M ammonium sulphate, and that this significantly 
depressed the level of plasma-bound iron in doses of 100 ug. 
The resolution of the ammonium sulphate fractional 
precipitation method did not appear to be sufficiently 
great to separate a more active fraction.
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Table 27 . - The depression of the level of plasma iron
in mice by toxohormone fractions prepared 
by ammonium sulphate precipitation.
!Ammoniumsulphateconcn.
Dose/mouse
..iml _ ..
Plasma iron level (ug/100ml)
Percentagedepression
.. Î'i
P
water 203 ± 6* - —
0.39M 1000 197 - 15 - —
0.78m 1000 217 ± 12 — —
1.17M 1000 2T2 ± 8 — -
1.56m 1000 136 ± 12 33.0 <0.01500 182 i 10 10.2 n.s.
%95M 1000 83 ± 16 59.2 <  0.01500 143 i 8 29.6 < 0.01200 139 ± 13 6,8 n.s.
2.34M 500 89 r 13 56.3 <  0,01200 158 i 10 22.2 < 0.01100 173 i 14 14, & n.s.
2.73M 200 7k Ï 17 63.5 < 0.01100 131 Î 12 35.3 < 0.0133 192 i 12
■ ■ 1 mni 1 - -1- - .... ‘ ~ . .-.-
Results are expressed as the mean - standard error of 
6 mice
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Gat ion-exchange chromatography of crude toxohormone
The elution pattern obtained by chromatography of
crude toxohormone on Amber1ite OR-50 is shown in Figure 14 ,
Fraction A started to be eluted at pH 10,5 and the gradient
ended at pH 11,0. The starting buffer was 0,1M glycine-
NaOH buffer, pH 9,0,
Yunoki and Griffin (1960,1961), in a similar experiment,
used a starting buffer of pH 9»40, and their column was
eluted with a gradient to higher pH, obtained by the addition
of 0,1M NaOH through a 1000 ml mixing chamber. Figure 15
presents the elution pattern published by these workers,
Yunoki and Griffin claimed that the TH^ peak, their most
active fraction, was eluted between pH 9#47 and 9.52, and
their third peak, TH^, at pH 9,60« However, using theiro
data, calculation of the volume of NaOH which would have 
passed through the mixing chamber at the elution volumes 
shown for the TH2 and TH^ peaks suggested that the pH of 
the eluant at the point of elution of TH2 was about 10*6 
and that at the point of elution of TH^, the eluant would 
have had no effective buffering capacity, and a pH value 
approaching I4*
In the present experiment, no peak corresponding to 
THg of Yunoki and Griffin was eluted, probably because the 
pH was not increased above 11*0. The second group of
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fractions, {A«*D, Figure 14), to be eluted appeared to be 
comparable to the TH2 fraction of Yunoki and Griffin.
Fractions A, B, 0 and D (Figure 14) were desalted on 
Sephadex G-15, and the elution profiles obtained are shown 
in Figure 16. Sephadex G-I5 excludes molecules whose 
molecular weight is greater than 1500, and therefore peaks 
eluted with the void volume (50 mis) of the column were 
tested for toxohormone activity* The results of the bio­
assay are displayed in Table 28.
Table 28 ^ - The depression of the plasma iron level of mice 
by toxohormone fractions purified by column chromâto* 
graphy.
Toxo-hoi*mone fraction
----- -— j
Dose/ mouse .Lug)..„
Plasma iron level ,.___Xug/ippml)___
Percentagedepression P
jlkWMMwU ^-L ifyw 1IT1& Wifil nfrflt' r
water 195 i 5* -
A 35 69 ~ 9 64,6 <  0.015 115 - 15 41.0 <  0.01
B 25 ââ ± 7 54.9 <  0.015 122 i 9 37.4 <  0.01
C 30 72 - 10 63.2 <  0.015 131 i 7 32,S <  0.01
D 40 60 ± 5 71.1 < 0.015 117-6 -- ----- ------- -
40.0 \ 0.01
Results are expressed as the mean - standard error of 
6 mice,
0-2
0-2 /
Eco00CM
o 02
co
oc
♦ î—^XLU
0-2
10050
Elution volume in mis
Figure 16. Elution of crude toxohoimone fraotions 
chromâtographically separated on AM>erlite CR-'30, from 
Sephadex G--15* Blution was with distilled water, and the 
flow rate was 30 ml ./hour# The column size was 1.5 2c 8 5  cm, 
and the void volume 5 I mis.
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Yunoki and Griffin (I96I) obtained three sub-fractions 
of their TH2 peak (Figure 15) , and did not attempt to further 
purify these sub-fractions * Bioassay by the liver oatalase 
method revealed that all three sub-fractions were highly 
active, and Yunoki and Griffin concluded that they were 
dealing with a group of closely related substances, all 
possessing toxohormone activity^ The large molecular weight 
fractions ( 5 0 0 )  obtained by Sephadex filtration of the 
four peaks from the cation-exchange chromatography all 
exhibited very similar activity in the depression of plasma 
iron (Table 28), and therefore a test was made to determine 
whether or not these fractions contained identical material.
The large molecular weight fractions from the four 
Sephadex separations was pooled and re chromatographed on 
Amber1ite CR-50. In this case, a single low-profile peak
was obtained, extending over the elution volume previously 
occupied by peaks A - D (Figure 14)* Desalting on Sephadex 
G-I5 produced a single peak in the excluded volume. It 
would therefore appear likely that the biologically active 
material is a single molecular species, eluted from the 
cation-exchange resin over a broad pH range. The presence 
of peaks B - D could then be due to the elution of the several 
small molecular weight compounds, subsequently separated by 
the Sephadex gel filtration.
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A dose-response curve was drawn for the purified 
toxohormone sample and is shown in Figure 17. The curve 
shows excellent linearity over a dose range of 1 - 50 ug, 
beyond which the extent of the effect diminishes, indicating 
that toxohormone cannot reduce the level of plasma iron 
below a definite minimum (about 69^ for this preparation) , 
The toxohormone fraction obtained by pooling the large 
molecular weight fractions from the Sephadex separations, 
referred to as the purified toxohormone fraction, was used 
in all subsequent studies in this work.
Co
oeinaCL
o
co‘to(/)CD
CLCDT3
70 r
0 1.000 2000
Log^Q dose of purified toxohormone
in micrograms
Figure 17. The dose-response curve of the purified toxohormone 
fraction#
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Some studies on the physical properties and chemical 
composition of toxohormone
Ultracentrifugal analysis
The fringe displacement obtained in the present experi­
ment is shown in Plate 6. The plot of log.Q fringe dis­
placement versus the square of the distance from the centre 
of the rotor is shown in Figure
The fact that two slopes can be obtained from the graph 
indicates that the original solution of the purified toxo­
hormone subjected to sedimentation was not homogeneous 
containing two molecular species of differing molecular 
weights.
The weight average molecular weight for each species 
was calculated by substitution of the relevant slope obtain­
ed from the plot into the equation of Van Holde and Baldwin 
(195Ô), given on page 131, In this case the molecular 
weights obtained for the low and high molecular weight 
compounds were 0,000 and 14,000 respectively. These 
estimations of molecular weight are approximately because 
of several assumptions made in the calculation, namely, the 
values selected for the density of the solution and for the 
partial specific volume of the polypeptide were chosen on 
the assumption that toxohormone has typical protein 
characteristics. The solution was also assumed to have
PLATE 6
The fringe displaceiiicnt obtained in the ultracentrifiigal analysis of the purified toxoliormone fraction.
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ideal behaviour because of the dilute conditions of the 
experiment.
The only other ultracentrifugal analysis of toxohormone 
described in the literature was reported by Yunoki and 
Griffin (1961), who performed a sedimentation analysis on 
their TH^ fraction, using the Schlieren optical system^
The sedimentation pattern obtained was diffuse at 59,700 rpm, 
and the only conclusion that they could derive was that TH2 
had a relatively small molecular weight. They also calcul­
ated minimum molecular weights from the N-terminal arginine 
content, and found these to be around 6,000 (Yunoki and 
Griffin, 196I),
Trojanowski et al. (1969) determined the molecular 
weights of their purified toxohormone fractions by chromato­
graphy on a calibrated column of Sephadex G-25, utilising the 
fact that the elution volumes of globular proteins from 
Sephadex are largely dependent on their molecular weights 
(Whitaker, 1963) , The molecular weights thus determined 
were 5,000, 9,000 and 12,000, Although Trojanowski»s 
preparation was impure ( page 109) , these results show that 
there was no high molecular weight component present in any 
significant amount in his preparation*
The present results confirm that biologically active 
toxohormone is a relatively small polypeptide, whose
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molecular weight is in the order of 10,000*
Toxohormone, as originally isolated by Nakahara and 
Fukuoka (194^), or by Greenfield and Meister (195D, is 
non-dialyZable. It is interesting to note that subjection 
of their crude toxohormone preparations to proteolytic 
enzyme digestion results in a dialyzable substance, potent 
in vivo* and not precipitable by alcohol (Nakahara and 
Fukuoka, 1954)# Nakahara and Fukuoka (1958) have since 
interpreted these results to mean that toxohofmone in its 
elementary form may be a relatively small molecule, and 
that it may occur in tumour tissue for the most part in 
aggregate form, or as part of a larger molecule, constitut­
ing the non-dialyzable form* They further suggest that 
an association may occur with nucleic acids, because of the 
basic nature of many toxohormone fractions (page109)* 
Nagagawa (1952) showed that a substance with toxohormone 
activity in the urine of cancer patients is precipitated by 
alcohol in spite of the absence of nucleic acid in the same 
fraction, so that the possibility that toxohormone normally 
exists as aggregates of smaller molecular forms has not yet 
been excluded.
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Amino-acid analysis
The results of the amino-acid analysis of the purified 
toxohormone are shown in Table 29*
Table 29 * - The amino-acid composition of toxohormone,
1
Amino-acid Residues/ | 100 residues | Amino-acid Residues/100 residues
Aspartic acid 10*1 Threonine 3,8
Serine 4,6 Glutamic acid 10.1
Proline 8,6 Glycine 30.4
Alanine 7.4 Valine 6.3
Cysteine 1.6 Methionine Trace
Isoleucine 3,9 Leucine 7.2
Tyrosine Trace Phenylalanine 2.7
Lysine Trace Hist idine Trace
Arginine 1.7
. --------------------- — ;
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Yunoki and Griffin (I96I) performed an amino-acid 
analysis on their TH2 fraction from human malignant tissues, 
and noted a very high proportion of aspartic acid and 
glutamic acid, and, in common with the present results, 
very small quantities of the aromatic amino-acids.
Ono et (1957) purified a toxohormone extract from 
Ehrlich carcinoma by adsorption on cellulose powder, and 
analysed the amino-acid content of the peptide after 
hydrolysis by paper chromatography of the dinitrophenyl 
derivatives of the amino-acids. Here again, the proportion
of aspartate and glutamate was high, and the aromatic amino- 
acids virtually absent. These workers did not detect any 
cysteine or methionine in their hydrolysate, and the sulphur- 
containing amino-acids were present only in very small 
amounts in the toxohormone fraction prepared in this work 
(Table 29 # It is of interest that the same tendencies in 
amino-acid composition should be noted in two toxohormone 
fractions prepared from different tumours by different 
extraction techniques. It must be pointed out^ however, 
that Ono^s preparation was active only at a minimum dose 
of lOOug and probably contained a high proportion of 
biologically inactive material, sc that the data on amino- 
acid composition must be treated with caution*
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Absorpt ion spoctruiri
The absorption spectrum of the purified toxohormone 
fraction dissolved in distilled water is shown in Figure 19* 
The lack of a definitive maximum at 280 nm, normally expected 
in the absorption spectrum of a protein or peptide, may be 
due to the lack of aromatic amino-acids (Table 29 ) , which are 
responsible for the absorption in this region. The high 
absorption at 260 nm led to the suspicion that nucleic acids 
might be present, possibly in association with the peptide * 
Warburg and Christian (1941) showed that the percentage of 
nucleic acid present in a nucleic acid - protein mixture can 
be ascertained from the ®200 '^^ bio* Using the present
data nucleic acids could form an mpurity to the extent of 
2^  by weight.
The presence of nucleic acids was tested for by the 
orcinol method for the estimation of ribose, and the Ceriotti 
method for the estimation of deoxyribose*
No colour formation was detected in either of these 
tests, using a 4 mg sample of the purified toxohormone in 
each case. This leads to the conclusion that if either 
deoxyribose or ribose were present, the quantities involved 
were insufficient to be detected by the methods employed.
This being the case, any nucleic acid contamination of the 
toxohormone preparation would constitute less than 24, by 
weight.
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The effect of toxohormone lyDon the uptake of lysine into 
total protein of diaphia^m muscle from normal rats■.■f-ir-i <P .iiBip. •■ Ill I p . i n - T  itr m i - . - .  ^  m    ■  - n : ' - - nTiy " # - , i . r r -  n- i :  ««wt*
In view of the significant effects of the growth of the 
Walker 256 carcinoma upon the uptake of lysine into the 
proteins of rat diaphragm muscle, reported in Section 2, the 
effect of the purified toxohormone prepared from Walker 
tumour upon protein metabolism in the muscle was investigated 
The results shown in Table 30 show that the toxohormone, in 
common with the tumour, exerts an inhibitory effect upon 
incorporation of label into muscle protein.
Table 30. - The effect of 300ug toxohormone administered 
in vivo upon the uptake of lysine into total 
protein of diaphragm muscle from normal rats.
T ime aft er in je ct ion of toxohormone (hr)
0
27
51
C ount s/minut 0/ mg prot e in
W 6  Z
394 -  15
143 ± 7
PXPI
< 0.01 
0.01
Results are expressed as the mean i standard error of 4 rats. 
In this and the following table, P refers to the statistical 
significance of the difference between the values obtained 
for the control and for the toxohormone treated rats,
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Toxohormone was also tested for an effect upon the 
uptake of lysine into muscle protein when added directly 
to the Incubation medium. The results displayed in Table 31 
indicate that the inhibitory action of toxohormone on protein 
synthesis is not confined to the in vivo situation.
Table 31, - The effect of toxohormone administered in vitro 
upon the uptake of lysine into total protein 
of normal rat diaphragm muscle.
Counts/minute/mg protein P
Control 3â4 ± 25* -
Toxohormone 198 ± 12 < 0.01
Results are expressed as the mean - standard error of 
5 rats.
Toxohormone has been shown to interfere principally 
with the mocabolism of iron-containing proteins {See general 
introduction), Nakahara and Fukuoka (195^) suggested that 
because of the fundamental biological importance of many of 
these proteins, it would not be unreasonable to suggest that 
cancer cachexia might ultimately be related to toxohormone 
activity. The same authore suggested that toxohormone
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might be responsible for the induction of a hormonal 
imbalance in the tumour-bearing host, which could contribute 
to the cachectic state (Nakahara and Fukuoka, I961).
The present results have confirmed that toxohormone 
has an inhibitory effect upon protein synthesis in muscle, 
and the fact that this activity is also evident in vitro. 
Table 31, indicates that the muscle itself could be a sits 
of action of toxohormone, and that its effect on muscle 
protein need not be a consequence of a general disturbance 
of the metabolism of the host.
GSSfBRAX. L'ISCUSSIOrr
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It was shown in Section 1 that diaphragm muscle was 
subject to both loss of weight and loss of protein 
during the growth of the Walker 256 carcinoma. The 
percentage distribution of the intracellular proteins was 
altered, the loss of contactile proteins being 
significantly greater than the loss of sarcoplasmic 
proteins. This finding, similar to the results obtained 
for the gastrocnemius and soleus muscles by Clark and 
G-oodlad (l97l) , confirmed that the diaphragm is one of 
the muscles affected by tumour growth.
The incorporation of labelled lysine into mixed 
muscle proteins from tumour-bearing animals was greatly 
decreased (Section 2), and, as in the experiments on the 
quantitative depletion of muscle proteins, a differential 
effect was observed on the two protein fractions examined. 
The sarcoplasmic proteins showed a slight but persistent 
increase in incorporation, whilst the uptake of radioactive 
amino-acid into the myofibrillar fraction was greatly 
reduced. There has been much evidence recently that 
réutilisation of labelled amino-acids, following a single 
injection, can obscure the true processes of protein 
synthesis and catabolism (Henshaw et al., 1968; Can and 
Jeffay, 1967; Waterlow and Stephen, 1968; Klevecz, 1971).
It seems probable, however, that the influence of the size
of the intracellular aniino-acid pool may be less in vitro 
than in vivo (Hider et aJL., 1969, 1971; Waterlow and 
Stephen, 1968; Millward, 1970a) and Clark and Coodlad 
(unpublished results) have shown that polysomes isolated 
from the gastrocnemius muscle of tumour-bearing rats show 
50^ less activity in a cell-free incorporating system than 
polysorn.es from normal muscle. It %TorJ.d appear. thrrefc^e . 
that the decreased incorporation of label into the protein 
fractions noted in this work can be attributed to a true 
inhibition of protein synthesis in the muscle from the 
tumour-bearing animal. The methods used in these 
experiments would not detect any alteration in the rate 
of protein catabolism which might result from the action of 
the tumour, and this factor cannot be eliminated as a 
possible contributory element in the present results.
Atrophy of skeletal muscle occurs as a result of 
a number of pathological conditions other than tumour growth ^ 
such as muscular dystrophy (Milhorat, 1967), denervation 
(Zsk, 1962), starvation (Millward 1970b) or glucocorticoid 
treatment (Kochalcian and Robertson, 1951).
Millward (1970b) showed that the rate of synthesis 
of sarcoplasmic protein in the muscles of starved animals 
fell to about 50^ of the control level, but that the 
catabolic rate remained unchanged. With the myofibrillar
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fraction, there was again a profound drop in the synthesis 
rate during starvation, accompanied by an increase in the 
rate of catabolism. Waterlow and Stephen (1966) and 
Millward (1970b) have shown that over long periods of 
starvation or protein deficiency, the loss from both 
fractions of protein is equal.
In genetically dystrophic mice, various investigators 
have observed a normal or increased incorporation of 
radioactivity into muscle protein following the in vivo 
injection of labelled amino-acids (ICruh e± al., I960; Simon 
et al., 1962; Coleman and Ashworth, 1959; Srivatava and 
Berlinguet, 1966; Weinstock, 1966), indicating that the 
synthesis of muscle proteins in maintained or even increased 
in dystrophic muscles. This finding would imply an 
increased catabolism in such muscles, to account for the 
observed atrophy, and increased catheptic activity has in 
fact been reported in nutritional muscular dystrophy 
(Weinstock, 1966). Berlinguet and Srivatava (1966) have 
suggested the presence of a specific muscle protease in 
dystrophic muscleso
That inn.ervation plays an important role in the 
functional and metabolic activity of skeletal muscle can be 
shown by reversal of the nerve supply of tonic and phasic 
muscles, which results in a corresponding reversal of both
the functional and chemical c]'aractoristies of the two 
muscle types (Guth ot al, 1968). There arc conflicting 
ideas concerning the influence of denervation upon muscle 
protein metabolism (Schapira et al., 1953; Padieu, 1959; 
Pater and Kohn, 1967), but the work of Goldberg (1969) 
suggests that there is an. increased catabolism of muscle 
protein, especially affecting the myofibrillar fraction, 
accompanied by a decrease in protein synthesis. In vitro 
studies on frog log muscle have tended to support this 
theory (Muscatcllo ^  al., 1965 ; Hargreth et , 1966), 
although Kollosi and Balogh (1969; found the protein 
response to denervation to be genus ' characteristic.
Furthermore, there is evidence to suggest that the 
response of the diaphragm to severance of the phrenic nerve 
is probably unique. Harris and Manchester (1966) noted a 
transitory hypertrophy, accompanied by an elevation of 
incorporation into diaphragm muscle proteins, following 
denervation. The increased catabolism in the denervatcd 
muscle has been associated with increased lysosomal 
activity (Pellegrino and Franzini, 1963; Pollack and Bird, 
1968).
Glucocorticoid-induced atrophy has also been shown 
to be due to increased catabolism, but in this case both 
myofibrillar and sarcoplasmic fractions are decreased by the
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same amount (Goldberg, 1969), and the increase in catabolism 
is probably not due to increased lysosomal activity, 
(Weissman and Thomas, 1964). It was pointed out in the 
Introduction that tumour-bearing rats are not diabetic, 
although they appear to show a decreased response to a 
glucose test-load. It was shown in Section 2 that insulin 
has a reduced stimulatory effect upon the incorporation 
of label into muscle proteins from tumour-bearing animals, 
indicating that there may be some interference with the 
mechanism of insulin action. Wool et al(1968) have shown 
that injection of insulin into normal rats appears to cause 
a qualitative rather than a quantitative change in the 
protein synthetic capacity of normal muscle polysomes, 
and Young pt al. (1968) showed that in this situation 
the proportion of large polysomes in muscle is increased. 
This is consistent with the observation in the present work 
of an increase in the incorporation of label into the 
myofibrillar proteins of normal muscle, with relatively 
little effect on the sarcoplasmic fraction. The response 
of polysome aggregation to insulin has been shown to be 
diminished by fasting for 2 days (Young et al., 1968), and 
it is possible that any condition of the animal which tends 
to suppress protein synthesis such as fasting or tumour 
growth will suppress the response to insulin.
Thus the systemic effects of the tumour do not appear to 
be explicable in terms of any interference with the 
nutritional or hormonal state of the animal, The 
atrophies produced by glucocorticoids, muscular dystrophy 
and denervation have been attributed, either wholly or 
partly, to increased catabolism within the muscle cell. 
While the role of protein catabolism in carcinomatous 
cachexia has not been investigated, there is evidence that 
there is no increase in the lysosomal population or the 
free acid phosphatase activity in muscles from tumour- 
bearing animals (Goodlad and Olarÿ, unpublished results). 
The atrophy of the denervated muscle appears to result 
from mechanisms which are in direct contrast to those 
operative in work-induced hypertrophy (Goldberg 1969), and 
the role of muscular paralysis in denervation requires 
to be elucidated.
Most important, however, is the conclusion from the 
present results that the effects of the tumour upon muscle 
protein metabolism are not consistent with the * Nitrogen 
trap* theory, proposed by many early workers (see 
Introduction). The patterns of protein depletion and 
protein synthesis in muscles from starved and tumour- 
bearing rats are quite different (Sections 1,2; Sobel,1966; 
Waterlow and Stephen, 1968; Millward, 1970b). This
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conclusion was supported by the evidence that 
supplementation of the incubation medium in the present 
experiments with either high concentrations of lysine, or 
with a mixture of amino-acids, does not alleviate the 
inhibition of incorporation of labelled lysine into muscle 
proteins of the tumour-bearing rat. This finding rules 
out the possibility that the observed inhibition is due to 
a deficiency of one or several amino-acids essential for 
protein synthesis.
Although imbalance induced in both circulating amino- 
acid levels and hormone levels will undoubtedly contribute 
to the gross effect observed in the tumour-bearing animal, 
it seems improbable on the basis of the evidence presented 
in the Introduction and in the body of this work that the 
primary mechanism of tumour action could be attributed to 
such an imbalance.
It is now well-documented that depression of liver 
oatalase activity and the level of plasma-bound iron are 
inevitable corollaries of tumour growth in an animal 
(see Introduction). These effects have been attributed 
to the action of toxohormone, a toxin secreted by the 
tumour (Nakahara and Fukuoka, 1948). The history of 
toxohormone and the evidence for its humoral nature are 
presented in the Introduction (page 23 ).
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To evaluate the role of toxohormone in tumour- 
host relations it is necessary to establish the type of 
biological effects which can be produced in normal animals 
by the injection of an isolated toxohormone fraction.
The first, and most often described effect was that of the 
depression of the activity of the enzyme liver oatalase 
(Nakahara and Fukuoka, 1948). Several other effects on 
iron metabolism have been reported, notably a decrease in 
the level of liver ferritin (Hoshizima, 1957) and an 
increase in liver protoporphyrin (Ono ^  al., 1956). The 
latter finding reflects the reduced ability of the liver of 
toxohormone-treated animals to synthesis oatalase (Hozumi 
and Sug imura, 1952).
As reported in Section 5 of this work, toxohormone 
was found to reduce the incorporation of labelled amino- 
acid into the protein of normal rat muscle quite dramatically 
both in vivo and in vitro. In the in vivo experiments, 
the muscles were exposed to the toxohormone in circulation 
in the rat, and incubated in a medium free of toxohormone.
The fact that an inhibition of uptake of label was observed 
under these condition indicates that the effect of toxo­
hormone was not readily reversible, and could support the 
hypothesis that toxohormone was acting directly upon the 
muscle, rather than through any intermediate metabolic
16 4
processes. That this was the case was demonstrated by 
the direct in vibro action of toxohormone upon the 
incorporation of label into normal muscle protein.
The apnaront irreversibility of the effect on 
muscle protein is interesting in view of the fact that 
Kampschmidt et aJ,(l959) showed that the effect of toxo­
hormone upon liver oatalase and plasma iron were trans­
itory, these parameters being restored to their normal 
levels 96 and 48 hours respectively after a single 
injection of toxohormone. However, the same workers 
showed that the alterations in organ weights displayed 
no signs of recovery at the longest time interval studied.
The question of the normal function of toxohormone 
in the non-neoplastic cell has not been discussed to a 
groat extent in the literature, yet there seems little 
doubt that a toxohormone-like substance can be isolated, 
admittedly in small amounts, from certain normal tissues. 
Spleen appears to be a particularly good source of such 
material (Day ^  al.,1954; Nixon and Zinman, 1966). A 
recurring idea has been that toxohormone is toxic only 
when produced in abnormal amounts by the tumour, and that 
in normal colls it functions either specifically as a 
regulator of liver oatalase synthesis (Nakahara and 
Fukuoka, 1958) or, perhaps more reasonably in view of the
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wide range of effects, as a general regulator of metabolic 
activity ( G-roenstoin, 1955 ) .
The evidence presented in this work suggests that 
toxohormone does play an important part in the mediation 
of the effects of the tumour, but much work remains both 
in the further purification and characterisation of the 
material, and in the elucidation of the mechanism of its 
action. Of immediate interest would be the investigation, 
using the methods described in this work, of the effect of 
toxohormone upon the incorporation of label into the sarco­
plasmic and myofibrillar protein fractions of normal muscle, 
in order to discover if the characteristic effect of the 
tumour upon the myofibrillar fraction alone is repeated. 
Another useful line of research would be the interaction 
of toxohormone and insulin, in view of the fact that 
insulin appears to have a greatly reduced effect in the 
tumour-bearing animal. Insulin has no stimulatory effect 
when added directly to a cell-free system from muscle 
(Wool et al, 1968), indicating that its mechanism of 
action could be primarily due to an effect upon the cell 
membrane. Similar studies with toxohormone could throw 
a great deal of light upon its site of action and the 
mechanism of its operation.
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1. The effect of the growth of the Walker 256 carcinoma 
upon various aspects of rat diaphragm protein
metabolism was investigated.
2. Microscopic examination of diaphragm muscle from
tumour-bearing rats revealed that the mean muscle 
fibre diameter was reduced compared with the normal 
animal.
3. The extracellular space of both * cut * and * intact'
diaphragm preparations was measured, using sorbitol 
and inulin as extracellular markers. No differences 
were observed in the extracellular space of both 
types of diaphragm preparation from normal and 
tumour-bearing rats, using sorbitol as the marker.
With inulin as marker, the extracellular space was
much smaller in the * cut * diaphragm preparation from 
the tumour-bearing animal.
4* Quantitative analysis of diaphragm muscle showed that
the muscle lost weight during the growth of the 
tumour and that part of the weight loss was due to 
the loss of protein. Further, the loss of contractile 
proteins appeared to be more extensive than the 
loss of sarcoplasmic proteins. rz5. The in vitro incorporation of H~lysine into mixed
proteins of rat diaphragm was shown to bo greatly
f
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reduced by the growth of the tumour. This effect 
seemed to be directed principally at the myo- 
fj.brillar proteins* The inhibition was not 
alleviated by the addition of either high concen­
trations of lysine or a mixture of amino-acids to 
the incubation medium.
6. Normal diaphragm muscles incubated in serum from a 
tumour-bearing rat exhibited a greatly decreased up­
take of labelled lysine into the myofibrillar 
proteins, and this pattern was not altered by 
supplementation of the medium with a mixture of 
amino-acids.
7. The stimulatory effect of insulin upon muscle protein 
synthesis was greatly reduced by the growth of the 
tumour. In the normal animals studied, the effect 
of insulin seemed to be directed principally towards 
the myofibrillar proteins
8. A toxohormone fraction was prepared from Walker
tumour tissue by an acetic acid extraction method,
and purified by cation-exchange chromatography and 
gel-filtration. The biological activity of the 
preparation was assayed by measurement of its effect
upon the plasma iron level in mice.
9. The effect of the purified toxohormone fraction upon
]ô9
muscle protein synthesis was investigated both 
in vivo and in vitro, and the toxohormone was 
observed to exert a profound inhibitory effect upon 
the incorporation of labelled lysine into .mixed 
intracellular muscle proteins.
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APPENDIX
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This a m  en Cl ix contains the data-'pro ces sing programme written i:
in Fortran IV for the IBM 360/44 computer. The programme 
was stored on RAX disc, and input data could be read from 
punch* cards, paner tano or a remote teletype terminal.
The program: e is designed to calculate the snecific 
activities of muscle protein fractions, incubated in medium 
with and without the addition of insulin. The programme 
also nerforms a three factor analysis of variance upon the 
calculated date.
The abbreviations used are as follows:
TMI: tumourvbearing animal, myofibrillar protein fraction,with insulin added to the medium.
TSI: tumour, sarcoplasmic, insulin added.
tumour, myofibrillar, no insulin added.
TSS: tumour, sarcoplasmic, no insulin added.
OMI: control, myofibrillar, insulin added.
CSX: control, sarcoplasmic, insulin added.
CMS: control, myofibrillar, no insulin added.
OSS: control, sarcoplasmic, no insulin added.
Data is read in as follows :
Card 1: number of muscles in each group (CP); backgroundcounts on scintillations counters (BCD).
Card 2 : counts/minute TMI 1; weight in mgs. TMI 1,
Card 3: counts/minute TMI 2; weight in mgs. TMI 2.
Card n: counts/minute CSS (CP); weight in mgs. gSS (CP)
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Output provides computed values for tho specific activities 
of oaoh of the protein samples, the mean and the standard 
error of the mean for each group, and an analysis of the 
variance between each of the eight groups#
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